I. Introduction {#sec0001}
===============

Viruses are obligate intracellular parasites. Unlike their hosts, they cannot replicate by growth or division but use their genomes to redirect host cell processes to produce all the components needed to make new viruses. Virus replication and assembly are often confined within specific intracellular compartments called virus factories, viroplasm, or viral inclusions. These are thought to provide a physical platform to concentrate new genomes and proteins involved in replication and assembly, and this is likely to increase the efficiency of virus production. The formation of specialized sites of replication can involve extensive reorganization of cellular cytoskeleton and membrane compartments. This can lead to cell rounding and swelling and a "cytopathic effect" that has been documented for many years ([@bib0294], [@bib0299]). Recent advances in microscopy, such as live cell imaging and tomography, combined with the power of reverse genetics, are now allowing the cytopathic effect to be redefined in terms of specific effects of viral proteins on specific cellular processes rather than an overwhelming assault on the cell in preparation for cell lysis.

There is considerable interest in understanding how virus infection leads to the large changes in cellular organization required to produce complex replication sites. In the simplest model, virus replication sites would form passively through self‐association of viral components and exclusion of host organelles. Viruses, however, require a considerable number of host proteins to facilitate replication, and there is increasing evidence that these are specifically transported to sites of replication. Host proteins may move to replication sites because they are actively recruited by binding to specific viral proteins. Alternatively, viruses may transport viral and host material to replication sites by subverting host defences against infection \[reviewed by [@bib0174], [@bib0388]\]. The large scale changes in cellular membrane and cytoskeletal organization, which occur during the formation of replication sites, can offer further benefit to viruses. Rearrangement of the cytoskeleton can, for example, facilitate virus release, and the block in the secretory pathway seen during infection with positive‐stranded RNA viruses can reduce release of inflammatory mediators and protect against innate and acquired immune responses. This is a broad subject of considerable interest to virologists and cell biologists, and we have benefited from excellent reviews that have been published ([@bib0199], [@bib0256]). In writing this chapter, we have concentrated on describing sites of virus replication in the context of the cell in which its replication takes place. We have illustrated these concepts with reference to replication sites produced by many different viruses and, where possible, described how virus replication impacts on the functioning of the host cell.

II. Viroplasm, Virosomes, Factories, and Inclusions {#sec0002}
===================================================

Virus replication sites have been studied for many years and have evolved their own terminology. Early studies of poxvirus replication ([@bib0080], [@bib0231]) describe electron‐dense aggregates and amorphous material induced early during infection called viroplasm. Viroplasm has also been used to describe similar structures induced during infection with *Poliovirus* ([@bib0081]). Viroplasm is often concentrated within perinuclear areas that exclude host organelles. Viroplasm is thought to indicate sites of virus replication, and concentrations of viroplasm have been called virosomes, or virus factories, to reflect an organelle involved in virus production. Virus infection also produces inclusion bodies. As a working definition, these can be considered to form later during infection. They can form virus factories once virus production has peaked, and/or at other sites in the cell they probably arise from an accumulation of viral proteins that do not become incorporated into viruses.

III. Membrane Rearrangements Occurring During the Replication of the Positive‐Stranded RNA Viruses {#sec0003}
==================================================================================================

The positive‐stranded RNA viruses encode nonstructural proteins (NSP) that cause proliferation and modification of membranes of the host secretory pathway. The membranes are thought to provide a physical framework or "replication complex" that concentrates the cellular and viral components required for virus replication ([@bib0029], [@bib0103], [@bib0123], [@bib0128], [@bib0203], [@bib0326], [@bib0370]). Assembly of the replicase on membranes, rather than the cytosol, may also help viruses evade host defence pathways that monitor cells for double‐stranded RNA (dsRNA) intermediates indicative of virus replication. The replicase complexes of all the positive‐stranded RNA viruses contain an RNA‐dependent RNA polymerase (RdRp), a protein with NTPase and helicase activity, and in many cases a methyl transferase to cap viral RNA. These proteins are generated from the viral polyproteins by viral proteases, and are then targeted to membranes in ways that differ depending on virus family ([Fig. 1](#fig0001){ref-type="fig"} ).Figure 1The replicase proteins of positive‐stranded RNA viruses are directed to membranes by NSP with membrane‐targeting information. (A) Picornavirus. The replication complex contains 3D, the RdRp (red), and 2C which has NTPase and helicase motifs (purple). The 3D polymerases do not have membrane‐targeting information but are synthesized as a 3ABCD precursor. 3ABCD is processed to 3AB by the 3C protease (red triangle) and a hydrophobic domain in 3A targets 3AB to the cytoplasmic face of ER membranes. 3AB binds directly to 3D and this targets the polymerase to the replication complex. The replication complex also requires 2BC and 2C proteins that are targeted to membranes via their own hydrophobic domains (black lines). (B) Flavivirues. The replication complex is encoded at the C‐terminus of a polyprotein that is processed by the NS2 protease (red triangle). NS5B is the RNA‐dependent polymerase (red), and NS3 acts as helicase (purple). NS4B is a polytopic membrane protein inserted into the ER cotranslationally. NS4A, 5A, and 5B have hydrophobic domains (gray lines) that allow posttranslational insertion into the cytoplasmic face of the ER membrane. NS3 is recruited into the complex by associating with NS4A. (C) Alphavirus. The NSP1234 polyprotein is processed by a protease activity in the C‐terminus of P2 (red triangle). The polyprotein is anchored to the cytoplasmic face of endosome and lysosome membranes by a hydrophobic region at the N‐terminus of P1. P1 also acts as the methyltransferase (yellow). P2 encodes the helicase (purple) and P4 is the RdRp (red). The P123 precursor associates with P4 and generates negative‐stranded RNA. Further processing produces a complex of separate P1, 2, 3, and 4 proteins that produce positive‐stranded RNA. (D) Nidoviruses. The Nidovirales order comprises the Arteriviridae, Coronaviridae, and Roniviridae families. The replicase gene is composed of two open reading frames termed ORF1a and ORF1b, both of which encode complex polyproteins. Arterivirus ORF1b encodes NSPs 9--12 including the RdRp (NSP9, red), helicase (NSP10, purple). The ORF1b reading frame lacks hydrophobic domains able to target the replicase to membranes. Proteins necessary for membrane targeting (brown and blue) are encoded by ORF1a (NSP2, 3, and 5). For the CoVs, for example, MHV and SARS‐CoV transmembrane domains are located in NSP3, 4, and 6, and helicase and polymerase proteins are NSP12 and 13, respectively. ORF1b also contains a methyltransferase (NSP16, yellow).

A. Regulation of membrane traffic in the early secretory pathway {#sec0004}
----------------------------------------------------------------

Membrane rearrangements by the positive‐stranded RNA viruses arise from modifications of membrane compartments in the early secretory pathway. The secretory pathway is carefully regulated in cells, and subversion of this pathway by viruses involves interactions between viral proteins and the host proteins that control membrane traffic. For some viruses we are beginning to understand how this is achieved. It is therefore useful to review briefly what is known about the control of membrane traffic at the start of the secretory pathway. Membrane proteins and proteins secreted by cells are synthesized by ribosomes attached to the cytoplasmic face of the endoplasmic reticulum (ER). Proteins destined for transport to the Golgi apparatus, or the plasma membrane, are folded by chaperones and assembled in the lumen of the ER, and transport to the Golgi apparatus and beyond involves a series of transport vesicles. The formation of these vesicles is controlled by coat proteins that are recruited from the cytosol. They select cargos for transport into the secretory pathway and facilitate vesicle formation by inducing membrane curvature ([@bib0030]).

Movement from the ER involves a coat made from COPII proteins that localize to specific domains of the ER called ER exit sites (ERES), or transitional ER. Vesicle budding from ERES requires the small GTPase, Sar1p. Binding of GTP to Sar1p translocates Sar1p from the cytosol onto ER membranes. Here, Sar1p‐GTP recruits cargo proteins into ERES and seeds polymerization of the COPII coat containing Sec13--Sec31p proteins and production of 60‐ to 80‐nm‐diameter vesicles. Movement of vesicles from the ER to the Golgi apparatus requires microtubules and the dynein/dynactin motor protein. The vesicles fuse with a series of membranes that lie between the ER and the Golgi apparatus called the *E*R‐*G*olgi *i*ntermediate *c*ompartment (ERGIC), or tubulovesicular structures, and specific fusion with ERGIC membranes is determined by a complex of proteins called *t*ransport *p*rotein *p*article 1 (TRAPP1). TRAPP1 proteins tether the vesicles on ERGIC and Golgi membranes, allowing interactions between vesicle and target SNARE (soluble *N*‐ethylmaleimide‐sensitive factor attachment protein receptor) proteins to facilitate membrane fusion. The SNARE interactions are controlled by vesicle‐specific small GTPases called rab proteins ([Fig. 2](#fig0002){ref-type="fig"} ).Figure 2Protein trafficking in the early secretory pathway. 1. Anterograde transport from the ER to the ERGIC is mediated by COPII‐coated vesicles. Formation of COPII coats is regulated by the Sar1p‐GTPase. Binding of Sar1p to the ER requires binding of GTP and this is facilitated by the Sec12p‐GTP exchange protein. Sar1p‐GTP recruits the Sec23--Sec24p subcomplex (light blue) of the COPII coat and this recruits cargo proteins (light green) to ERES. The Sec23--Sec24p subcomplex then recruits the Sec13--Sec31p proteins (purple) that induce membrane curvature and formation of a vesicle. Hydrolysis of GTP on Sar1p by Sec23p results in coat disassembly. The vesicle docks with ERGIC membranes by binding tethering proteins and interactions between v‐SNAREs and t‐SNAREs results in vesicle fusion. 2. Retrograde transport from the ERGIC to the ER provides a pathway to retrieve proteins from the ERGIC and Golgi apparatus and is mediated by COPI‐coated vesicles. Formation of COPI coats is regulated by the Arf1‐GTPase. Binding of Arf1 to the ERGIC requires binding of GTP and this is facilitated by the GBF1 and BIG1/2 GTP exchange proteins. Arf1‐GTP recruits the COPI coat complex (dark blue), which induces membrane curvature and formation of a vesicle that returns to the ER.

Further sorting events in the ERGIC and early Golgi involve a second complex of coat proteins called COPI. The COPI complex contains seven proteins (α, β, β′, γ, δ, ɛ, and ζ COP proteins), which generate vesicles that take proteins from the ERGIC and Golgi apparatus back to the ER through a retrieval pathway ([Fig. 2](#fig0002){ref-type="fig"}). The COPI proteins are recruited from the cytosol by the Arf1‐GTPase. Activation of Arf1 requires binding to GTP and is facilitated by GTP exchange protein, Arf‐GEF. Arf1‐GTP inititates coat assembly while hydrolysis of GTP by Arf1 leads to coat disassembly. This disassembly is stimulated by an Arf1‐GTP‐activating protein (Arf‐GAP) that promotes GTP hydrolysis by Arf1. A possible role for Arf1 in the generation of vesicles during picornavirus replication has been the focus of much work following the observation that *Poliovirus* replication is blocked by brefeldin‐A (BFA), a drug that inhibits the recruitment of Arf1 onto membranes ([@bib0212]).

Membrane vesicles are also produced in cells in response to starvation. This pathway, known as autophagy, is used as a part of a quality control system that removes long‐lived proteins and damaged organelles from the cytoplasm and has been shown to provide a defence against intracellular pathogens ([@bib0089], [@bib0174], [@bib0189], [@bib0334]). The origins of the membranes formed during autophagy are unclear but may be derived from the ER ([@bib0292]). Autophagy is suppressed by the *t*arget *o*f *r*apamycin (TOR) kinase and is activated by conditions that lead to inactivation of TOR. This leads to the production of membrane crescents in the cytoplasm, called isolation membranes, which mature into double‐membraned vesicles of 500‐ to 1000‐nm diameter called autophagosomes. This maturation engulfs small quantities of cytoplasm, and any organelles or pathogens present at sites of autophagy become trapped within autophagosomes. The autophagosomes ultimately fuse with lysosomes resulting in degradation of their content. Autophagosomes are of interest because infection of cells with picornaviruses and coronaviruses (CoVs) can generate double‐membraned vesicles that may be related to autophagosomes.

In addition to supplying membrane and proteins to the secretory pathway, the ER acts as a major site of lipid synthesis. As a consequence, the ER contains a large quantity of membrane, and this is organized into a complex reticulum made from tubular and lamella structures ([@bib0034]). The smooth ER increases in response to a buildup of ER membrane proteins and can be organized into lamellae or concentric whorls called organized smooth ER (OSER). Structures similar to OSER are also seen during virus replication.

B. Picornavirus replication induces numerous membrane vesicles {#sec0005}
--------------------------------------------------------------

### 1. The picornavirus replicase {#sec0006}

Picornaviruses are nonenveloped positive‐stranded RNA viruses. The genome encodes a large polyprotein that is processed to generate capsid proteins from the P1 region and nonstructural replicase proteins from the P2 and P3 regions. Picornavirus 3D contains the RdRp, while 2C has NTPase and helicase motifs. The 3D polymerase does not have membrane‐targeting information but is synthesized as a 3ABCD precursor. 3ABCD is processed to 3AB by the 3C protease, and a hydrophobic domain in 3A targets 3AB to the cytoplasmic face of the ER. 3D binds directly to 3AB, and this targets the polymerase to the replication complex. The 3D polymerase of *Poliovirus* is believed to self‐assemble into a large ordered array on membranes, which is critical for binding RNA and RNA elongation ([@bib0198]). The replication complex also requires 2BC and 2C proteins that are targeted to membranes via their own hydrophobic domains ([Fig. 1A](#fig0001){ref-type="fig"}).

### 2. Membrane rearrangements induced by picornaviruses provide sites for replication {#sec0007}

The accumulation of large numbers of densely packed membrane vesicles in the cytoplasm is characteristic of a picornavirus infection ([@bib0028], [@bib0029], [@bib0064], [@bib0081], [@bib0326], [@bib0349], [@bib0350]). Studies have suggested that vesicles induced by *Poliovirus* are derived from the ER, either from COPII‐coated vesicles or from ER‐derived autophagic double‐membraned vacuoles ([@bib0029], [@bib0164], [@bib0315], [@bib0326], [@bib0350]). However, the detection of ER, Golgi, and lysosomal markers in membranes induced at later stages of infection by *Poliovirus* suggests that more than one organelle may contribute membranes to the replication complex ([@bib0326]). In interpreting these studies, it is important to consider if the vesicles observed are involved in replication, or if they represent a bystander response to virus infection. Evidence for a role of specific membranes in replication is provided by the presence of replicase proteins, or better still dsRNA or negative‐stranded intermediate viral RNA ([@bib0100]). Examination of cells infected with *Poliovirus* for the first appearance of negative‐stranded RNA suggests that this initial stage of replication starts on the ER. This is consistent with high‐resolution immunofluorescence microscopy ([@bib0315]) showing the *Poliovirus* 2B protein associated with ERES containing the Sec13--Sec31p proteins of the COPII complex. These sites exclude resident ER proteins, suggesting colocalization of 2B with COPII‐coated transport vesicles. Replication complexes containing negative‐stranded RNA then move on microtubules to a perinuclear area to initiate synthesis of positive‐stranded RNA ([@bib0100]).

### 3. Membrane rearrangements can be induced by expression of nonstructural proteins {#sec0008}

Membrane rearrangements have been studied by expressing individual, or combinations, of picornavirus proteins in cells. Most of this work has involved studies of *Poliovirus* proteins, and membrane rearrangements are reported for the 2B, 2C, 2BC, 3A, and 3AB proteins. *Poliovirus* 2B causes fragmentation of the Golgi complex ([@bib0322]). The 2BC and 2C proteins lead to vesiculation and tubulation and sometimes myelin‐like swirls of ER‐derived membranes ([@bib0004], [@bib0064]). Similar structures are induced by 2C and 2BC of hepatitis A virus ([@bib0362]). Expression of the *Poliovirus* 3A protein causes swelling of ER cisternae ([@bib0092]) and the disappearance of vesicles budding from the ER, while the 3AB protein also induces myelin‐like swirls of ER ([@bib0102]). The membrane rearrangements induced by expression of single proteins do not, however, mirror those observed in infected cells, and since myelin‐like modifications to the ER are also seen following overexpression of ER proteins \[reviewed by [@bib0034]\], their relevance to viral replication is unclear. Importantly for *Poliovirus*, it is a combination of 2BC and 3A protein expression that induces membrane structures morphologically similar to those seen in infected cells ([@bib0350]).

### 4. Membrane rearrangements may vary between different picornavirus families {#sec0009}

[@bib0128] have studied replication complexes formed by several different picornaviruses. *Encephalomyocarditis virus* (EMCV), parechovirus 1, and echovirus 11 induce clustered vesicles containing dsRNA in the perinuclear region of the cell. The precise nature of the vesicles varied with virus. Parechovirus 1 produced homogeneous vesicles of 70--100 nm, while membranes produced by EMCV and echovirus 11 were heterogeneous but more compact and associated with electron‐dense material. Differences for parechovirus 1 have also been reported by [@bib0181] who suggest that replication may occur on membranes derived from the late Golgi rather than early ER and ERGIC compartments. All three viruses, however, cause loss of ribosomes from the ER and lack of visible Golgi apparatus. The COPI coat protein β‐COP was found to colocalize with echovirus 11 replication complexes, but not with replication complexes produced by EMCV, again suggesting that vesicles produced by different picornaviruses may differ. Infection with *Foot‐and‐mouth disease virus* (FMDV) also results in loss of ribosomes from the ER and an accumulation of heterogeneous vesicles to one side of the nucleus ([@bib0229]).

High‐pressure freezing can be used to increase the preservation of cellular ultrastructure during processing for electron microscopy. Such analysis of cells infected with *Poliovirus* shows that the vesicles have two membranes suggestive of autophagosomes ([@bib0164], [@bib0350]). Double‐membraned structures containing electron‐dense material, and possibly viruses, were also revealed by the early work on *Poliovirus* ([@bib0081]). High‐pressure freezing has been used to compare FMDV and *Bovine enterovirus* (BEV). BEV produced heterogeneous membrane clusters similar to the rosettes described for *Poliovirus* ([@bib0101]). Many of the vesicle membranes have high electron density suggestive of double membranes and lie adjacent to accumulations of virus‐like particles. Clusters of FMD viruses were also associated with vesicles and electron‐dense material, but there were fewer double‐membraned vesicles ([@bib0229]). Immunofluorescence analysis of *Poliovirus* vesicles shows colocalization of replicase protein 3A and autophagy marker LC3, suggesting assembly of the replicase on autophagosomes. Similar work suggesting the use of autophagosomes during replication of CoVs will be described below. For *Poliovirus*, expression of 3A and 2BC, which produces vesicles similar to those seen in infected cells ([@bib0350]), can induce autophagy ([@bib0164]), and inhibition of autophagy reduces yields of extracellular virus. The results suggest that the autophagy pathway may facilitate the release of *Poliovirus* from cells, and it will be interesting to see if this is true for other enteroviruses that are resistant to the low pH and proteases present in lysosomes and autophagosomes.

### 5. Vesicle coat proteins may play a role during picornavirus replication {#sec0010}

Evidence that different members of the picornavirus family vary in the way that they interact with host membranes is provided by studies of virus sensitivity to BFA. BFA completely inhibits *Poliovirus* and echovirus 11 replication ([@bib0075], [@bib0128], [@bib0160], [@bib0212]) and partially inhibits parechovirus 1 replication ([@bib0128]) but not other picornaviruses such as EMCV ([@bib0128]) or FMDV ([@bib0229], [@bib0258]). BFA prevents assembly of COPI coats and this has generated considerable interest in understanding how COPI and COPII coats contribute to formation of the replication complex, and how BFA inhibits picornavirus replication. In cells infected with the highly BFA‐sensitive virus echovirus 11, β‐COP was recruited into the replication complex; in contrast, the replication complex formed by the BFA‐resistant EMCV did not contain β‐COP. This correlation suggests that BFA‐sensitive viruses may require COPI coats for replication ([@bib0128], [@bib0199]). Since COPII coats are resistant to BFA ([@bib0190], [@bib0262], [@bib0379]), it is suggested that COPII coats may provide the membranes for replication complexes formed by BFA‐insensitive viruses. The observation that *Poliovirus* replicase 2B protein is seen in ERES containing COPII proteins, but *Poliovirus* is sensitive to BFA, can be reconciled if this association of 2B with ERES is considered to be an early step in generation of membrane for the replication complex that precedes recruitment of COPI coat proteins. This is supported by work showing the movement of *Poliovirus* replication complexes containing negative‐stranded RNA from the ER to perinuclear sites ([@bib0100]).

Direct evidence that COPI coat proteins are required for picornavirus replication comes from studies of *Drosophila C virus* (DCV). DCV is a positive‐stranded RNA dicistronic virus that is similar to *Poliovirus* and replicates in a cytoplasmic compartment containing virus‐induced membrane vesicles. A genome‐wide RNA silencing screen identified six (α, β, β′, γ, δ, and ζ) of the seven COPI coat proteins as essential for virus replication. Furthermore, the formation of virus‐induced vesicles required β‐COP, but not COPII protein, Sec23p. Notably, small interfering RNAs against α‐COP, but not Sec23p, also slowed *Poliovirus* replication ([@bib0061]).

### 6. Arf proteins and Brefeldin‐A can modulate poliovirus and coxsackievirus replication {#sec0011}

The formation of COPI‐coated vesicles is regulated by the Arf1‐GTPase. The observation that BFA inhibits the replication of enteroviruses such as *Poliovirus*, and also inhibits the function of the Arf1‐GTPase, provides a second link between virus replication and COPI coats. Arf proteins are regulated by Arf‐GEFs that facilitate binding of GTP by removing GDP, and by Arf‐GAPs that increase hydrolysis of GTP by Arfs. Arf1‐GEFs are inhibited by BFA, and BFA therefore reduces levels of Arf1‐GTP in cells. The GEFs affected by picornavirus infection are *G*olgi‐associated *BF*A‐resistant protein (GBF1) and *B*FA‐*i*nhibited protein (BIG1/2). Work by [@bib0022], [@bib0023] indicates that infection of cells with *Poliovirus* increases intracellular Arf‐GTP levels fourfold, suggesting increased activity of Arf1‐GEFs or inhibition of Arf1‐GAP proteins. In the absence of virus, Arf1 is concentrated in the Golgi apparatus, but during infection with *Poliovirus* Arf1 staining fragments and colocalizes with replicase protein 2C. This suggests that infection leads to a redistribution of Arf proteins from the Golgi apparatus to the replication complex. The binding of Arf proteins to membranes is dynamic, with Arf‐GDP being released from membranes following hydrolysis of GTP. Cytosolic Arf1‐GDP would redistribute naturally to membranes enriched for the Arf1‐GEFs that facilitate loading of new GTP. Significantly, *Poliovirus* infection causes enrichment of GEFs in membranes containing replicase proteins, and this would provide a mechanism for increasing levels of Arf1‐GTP at sites of virus replication.

Translation of *Poliovirus* RNA on membranes *in vitro* provides an alternative means of studying the role of Arf proteins in virus replication. Replication is inhibited by BFA and peptides that function as competitive inhibitors of Arf ([@bib0075]), and for the most part, the assay mimics what is observed in infected cells. Translation *in vitro* leads to recruitment of Arf3 and Arf5 but not Arf6 ([@bib0023]) onto membranes. Suitable antibodies recognizing the ER‐associated Arf1 were not available for these experiments, so it is not known if Arf1 is also recruited to membranes during translation. Membrane recruitment of Arf proteins can be reconstituted by translation and expression of *Poliovirus* 3A or 3CD. *Poliovirus* proteins do not show intrinsic GEF activity, but 3A and 3CD will induce association of GBF1 and BIG1/2, respectively, with membranes *in vitro*. This raises the possibility that recruitment of 3A and 3CD to the replication complex during infection targets Arf‐GEF to virus‐induced membranes, which in turn increases local levels of Arf1‐GTP. This is thought to be necessary for replication because inhibition of Arf1‐GEF by BFA blocks replication, and replication can be rescued by overexpression of GBF1 ([@bib0023]). High levels of Arf1‐GTP would also increase recruitment of COPI proteins and be consistent with the work on DCV showing that COPI proteins are required for replication and vesicle production ([@bib0061]). A *Poliovirus* 3A mutant with a serine insertion at position 16 is unable to cause translocation of Arf to membranes ([@bib0022]). *Poliovirus* carrying the 3A mutation does not, however, show defects in replication, suggesting that Arf1‐GEF recruitment to membranes by 3A is not essential for replication. It is possible that during infection the defect in 3A is compensated for by 3CD. Interestingly, a BFA‐insensitive *Poliovirus* with mutations in the 2C and 3A proteins ([@bib0074]) induces vesicles and dispersal of the Golgi apparatus, which begs the questions, does this mutant use a different process for forming the replication complex, or do the mutations in 3A allow the proteins to compete with BFA for GBF1 recruitment?

The role of Arf proteins during coxsackievirus infection has also been studied. In common with *Poliovirus*, coxsackieviruses are enteroviruses and their replication is inhibited by BFA. Expression of coxsackievirus 3A causes loss of COPII coats from ERES, and an accumulation of 3A, COPII and a model secreted protein in both the ER, and tubular‐vesicular post‐ER structures containing ERGIC marker proteins. These effects closely resemble the effects of adding BFA to cells, suggesting coxsackievirus 3A may affect the function of Arf proteins. Coxsackievirus 3A affects the regulation of Arf proteins ([@bib0384]). Interestingly, the process differs to that described by [@bib0022], [@bib0023] for *Poliovirus* 3A translated *in vitro*. Expression of coxsackievirus 3A in cells caused loss of COPI and Arf1 from membranes, and there was redistribution of BIG1/2 and GBF1 from the Golgi apparatus into the cytoplasm. This suggests that coxsackievirus 3A reduces, rather than enhances, levels of Arf1‐GTP. Coxsackievirus 3A also caused redistribution of Arf1‐GAP to punctate structures suggestive of the ERGIC. A block in Arf1‐GEF activity, combined with recruitment of Arf1‐GAP, would reduce the levels of Arf‐GTP and inhibit membrane recruitment of COPI. [@bib0383] examined the effects of the 3A proteins of other picornaviruses and found that only the 3A proteins of enteroviruses bound GEFs. Intriguingly, Wessels' work contrasts with Belov in that they found the interaction of 3A with GEFs lead to a loss of Arf proteins from membranes. Why these differences are seen is, as yet, unknown but may be due to differences in cell type/methods used or differences in levels of 3A protein expression.

### 7. Picornavirus replication blocks protein secretion {#sec0012}

*Poliovirus* and coxsackievirus slow protein movement through the secretory pathway ([@bib0091], [@bib0382]). Expression of 2B, 2BC, and 3A individually were all able to slow secretion ([@bib0071], [@bib0091], [@bib0092], [@bib0372], [@bib0382], [@bib0383]), but for both viruses the 3A protein was found to have the greatest impact on ER‐to‐Golgi transport. *Poliovirus* infection, and the 3A protein expressed alone in cells, reduces surface expression of MHC class I, the TNF receptor, and secretion of β‐IFN, IL‐6, and IL‐8 ([@bib0065], [@bib0088], [@bib0090], [@bib0251]), and this may offer an immune evasion strategy to the picornaviruses. This is consistent with the observation that the ability of the coxsackievirus 3A protein to slow secretion may be important for virulence ([@bib0384]) and has led to studies of the mechanism of action of 3A in blocking ER‐to‐Golgi transport.

Deletion analysis has identified residues in the unstructured N‐terminal region of *Poliovirus* and coxsackievirus 3A as important for the block in host protein secretion ([@bib0065]). An N‐terminal proline‐rich region (particularly Pro19) is important for coxsackievirus block in trafficking ([@bib0382]). In *Poliovirus*, Lys9 appears important, and in the triple‐proline motif (positions 16--18), only the Pro18 is indispensable for inhibition of protein secretion ([@bib0065]). A serine insertion in 3A protein between Thr14 and Ser15, creating the 3A‐2 mutant virus ([@bib0025]), was found to abolish the ER‐to‐Golgi inhibition of protein trafficking but has little effect on virus replication or membrane rearrangements ([@bib0090], [@bib0092]). This important observation shows that the ability of 3A to inhibit protein secretion is separate from its role in membrane rearrangements and viral replication.

There is continuing interest in understanding how picornavirus proteins block secretion. *Poliovirus* 3A and 3CD, and coxsackievirus 3A, can interact with Arf‐GEF, but the downstream events are unclear. The recruitment of Arf‐GEF by *Poliovirus* 3A and 3CD would increase recruitment of Arf‐GTP to membranes of the replication complex. This would increase recruitment of COPI coat proteins into sites of virus replication and reduce the pool of COPI proteins available to the ERGIC and Golgi apparatus. Alternatively, inhibition of Arf‐GEF and recruitment of Arf‐GAP onto ERGIC membranes by enterovirus 3A would decrease membrane association of Arf‐GTP and again reduce recruitment of COPI onto ERGIC and Golgi membranes. Both mechanisms would reduce the formation of COPI vesicles, and as seen for BFA, block secretion. *Poliovirus* 3A also binds and inactivates L1S1, a component of the dynein--dynactin motor complex ([@bib0178]), which is required to move COPII‐derived vesicles from ERES to the ERGIC. As seen for expression of 3A, mutant L1S1 leads to disruption of the ER‐to‐Golgi traffic and reduction in plasma membrane receptors such as TNF receptor. It is possible that 3A may also slow ER‐to‐Golgi transport by binding L1S1.

#### a. Picornaviruses differ in the use of nonstructural proteins to block secretion {#sec0013}

The ability of 3A to inhibit ER‐to‐Golgi trafficking has not been conserved in all picornaviruses ([@bib0065], [@bib0071], [@bib0088], [@bib0224]). For example FMDV infection leads to reduced surface expression of MHC class I ([@bib0323]), but the FMDV 3A protein does not inhibit ER‐to‐Golgi transport ([@bib0224]). A lack of inhibition of secretion has also been reported for 3A proteins of human rhinovirus, hepatitis A, Theiler\'s virus, human enterovirus, and EMCV ([@bib0065], [@bib0383]). The 3A protein of human rhinovirus is unable to bind GBF1, or inhibit COPI recruitment to membranes, and this may explain its inability to slow secretion. Importantly, studies on FMDV have shown that the 2BC protein, or a combination of the processed products, 2B and 2C, inhibits protein movement from the ER to the Golgi apparatus ([@bib0224], [@bib0225]), and this may be similar for other picornaviruses with 3A proteins that do not block ER‐to‐Golgi transport.

A lack of effect of FMDV 3A on secretion does not result from an inability to bind membranes. FMDV 3A is recovered from postnuclear membrane fractions, and when expressed alone in cells it colocalizes with resident ER proteins. In common with 3A, picornavirus 2B, 2C, and 2BC proteins also contain membrane‐binding sequences. Sequence alignment of the 2B, 2C (2BC), and 3A proteins of different picornaviruses showed a high level of conservation between the 2C proteins, which contain an NTP‐binding site and predicted helicase motifs ([@bib0132]) but large variations in the sequences of the 2B and 3A proteins ([@bib0065], [@bib0224]), and these may explain their different abilities to block secretion. The FMDV 3A protein is, for example, much longer than 3A of enteroviruses, such as *Poliovirus*, and it does not contain the N‐terminal sequences thought important for *Poliovirus* 3A to block the secretory pathway.

The 2B protein of FMDV also locates to ER membranes but shows a more reticular pattern than the FMDV 3A protein ([@bib0224]) and can be seen in punctate structures aligned along the ER suggestive of ERES ([Fig. 3](#fig0003){ref-type="fig"} ). This is similar to the 2B of *Poliovirus* that colocates with both Sec13p and Sec31p of the COPII coat. As expected, FMDV 2C is also membrane associated. When expressed in cells, 2C produces faint ER staining, but mainly locates to bright punctate structures in a perinuclear region close to β‐COP, reminiscent of Golgi staining. The β‐COP staining is, however, fragmented suggesting dispersal of the Golgi apparatus, and there is not complete colocalization since 2C structures negative for β‐COP protein can also be seen ([@bib0225]). A similar location of FMDV NSP within the area of the cell occupied by the Golgi apparatus is seen in cells infected with FMDV, and again they do not colocalize with Golgi markers ([@bib0176]). The 2BC protein of FMDV is also recovered in postnuclear membrane fractions, but when expressed in cells, 2BC staining differs from that seen for the processed products, 2B and 2C ([Fig. 3](#fig0003){ref-type="fig"}). FMDV 2BC locates to punctate cytoplasmic structures and larger structures surrounding the nucleus that contain ER markers suggesting swelling of the ER. 2BC shows partial overlap with luminal ER markers but, unlike *Poliovirus* 2BC, does not colocate with the COPII marker Sec13p. The ER markers also appeared punctate in cells expressing 2BC, suggesting disruption of the ER ([@bib0224]). Interestingly, coexpression of 2B and 2C blocks secretion within post‐ER compartments, similar to those containing 2C. The site of block therefore seems to be determined by the subcellular location of 2C ([@bib0225]) and is consistent with the observation that the block in the presence of 2B can be redirected to the ER, if 2C is tethered to the ER by an ER retention sequence.Figure 3Subcellular location of Foot‐and‐mouth disease NSP encoded in the P2 region of the FMDV genome. Vero cells expressing FMDV 2B (top), 2BC (middle), or 2C (bottom) were fixed and permeabilized and processed for immunofluorescence. 2C and 2BC were located using antibodies specific for 2C (3F7) and 2B was located using an antibody raised against an epitope tag in 2B. Cells were counterstained using antibodies against ER luminal protein ERP57 (top and middle panels), or COPI protein β‐COP (bottom). Merged images are shown at higher magnification on the far left. See [@bib0224] for more details. Reprinted from [@bib0224] with permission from American Society for Microbiology.

C. Alphaviruses produce membrane invaginations and spherules {#sec0014}
------------------------------------------------------------

*Sindbis virus* (SbV) and *Semliki Forest virus* (SFV) are the best studied examples of alphavirus replication in mammalian cells \[reviewed by [@bib0319]\]. Early electron microscopy studies showed that vesicular structures called cytopathic vacuoles between 600‐ and 2000‐nm diameter, accumulated in infected cells. The vacuoles contained 50‐nm‐diameter vesicles called spherules, many of which were aligned along the inside face of the vacuole and attached by a neck to the limiting membrane. The neck was often seen connected to an electron‐dense matrix extending into the cytoplasm. The observation that the cytopathic vacuoles contained NSPs required for RNA replication, cofractionated with lysosomal enzymes, and could be labeled with endocytic markers ([@bib0123]), led to the conclusion that they are sites of viral replication derived from endosomes and lysosomes. In many cases, the vacuoles were also connected to the rough ER by filaments and granular material containing the RNA polymerase.

### 1. The alphavirus replicase is located Within invaginations in cellular membranes {#sec0015}

Alphavirus NSPs are synthesized in the cytoplasm and bind to endosomes and lysosomes to generate a replication complex. The replicase proteins are synthesized as a polyprotein (P1234). The P4 domain is the RdRp while P2 has NTPase and helicase activities, and P1 is the methytransferase required to cap RNA ([Fig. 1](#fig0001){ref-type="fig"}C). The P1234 polyprotein locates to endosome or lysosome membranes via an amphipathic peptide sequence in P1 ([@bib0318]). At this stage the P4 polymerase is cleaved from the polyprotein and functions with the remaining P123 protein to generate negative‐stranded RNA. Interestingly, once the P123 is processed to individual NSPs, the polymerase preferentially produces positive‐stranded RNA. Expression of individual NSPs does not lead to the formation of a cytopathic vacuoles or spherules. Formation of spherules requires interactions between NSP P1, P3, and P4 and the P123 polyprotein precursor complex ([@bib0318]).

*Rubella virus* is a member of the Togaviridae family within the *Alphavirus* genus. Cells infected with *Rubella virus* also contain vacuoles containing spherules and these colocalize with lysosomal markers, suggesting use of lysosomes for replication. A fibrous material connects the vacuoles to the ER ([@bib0186], [@bib0203]), again suggesting strong similarities with SFV and SbV. Members of the alphavirus superfamily share homologies between proteins required for RNA replication, and this extends to plant viruses. *Alfalfa mosaic virus* replicase proteins colocalize with the plant vacuole ([@bib0369]), and *Turnip yellow mosaic virus* uses the chloroplast outer envelope as a site for replication. Replication of *Tobacco mosaic virus*, a tobamovirus, is dependent on *Arabdopsis* proteins TOM1 and TOM2A that are integral membrane proteins of the tonoplast ([@bib0142]). The tonoplast is a membrane compartment within plants that surrounds the vacuole/lysosome, suggesting plant alphaviruses also use the endosome/lysosome system as a site of replication. Infection of plants with alphavirus‐like superfamily viruses can also induce the formation of spherules ([@bib0277]). There is evidence that *Tobacco mosaic virus* also uses the ER as a site of replication because the replicase enzyme and viral RNA are located on the ER of infected cells, and infection causes major changes in ER morphology ([@bib0293]), including ER aggregation and formation of lamella structures.

*Flock house virus* replicates in spherules in the outer membrane of mitochondria. The RNA polymerase ( protein A) of *Flock house virus* is the only protein required for RNA replication and is targeted directly to the mitochondrial outer membrane by hydrophobic amino acids at the N‐terminus. This sequence contains a mitochondrial localization signal and transmembrane domain that leaves the bulk of the protein exposed to the cytoplasm ([@bib0219]). *Brome mosaic virus* replicates in yeast and has been studied extensively. The 1a and 2a replicase proteins are produced from separate viral RNAs. The 1a protein contains a C‐terminal helicase domain and an N‐terminus required for RNA capping. 1a is targeted to the cytoplasmic face of ER membranes and recruits the 2a polymerase to the replication complex ([@bib0328]). Importantly, replication of *Brome mosaic virus* on the cytoplasmic face of the ER in yeast induces membrane invaginations of 50 nm that are very similar to the spherules produced in endosomes and lysosomes during alphavirus infection of mammalian cells.

### 2. Membrane invaginations and spherules induced by alphviruses share similarity with virus budding {#sec0016}

It has been suggested that the active formation of spherules to separate viral RNA from host responses is analogous to the coordinated assembly of viral proteins, which leads to capsid assembly, genome packaging, and budding ([@bib0002], [@bib0328]). The *Brome mosaic virus* replication complex contains viral 1a and 2a^pol^ proteins within spherules. Expression of 1a alone produces a shell containing hundreds of copies of 1a on the inside of 50‐nm spherules. In a capsid assembly model ([@bib0328]), vesicles of uniform size would arise if the 1a protein first made a planar lattice with hexameric symmetry on membranes and achieved curvature by localized rearrangement of 1a into pentamers. Interestingly, the formation of spherules is dependent on the relative levels of 1a and 2a^pol^. When levels of 2a^pol^ are high, the spherules are lost, and 1a and 2a^pol^ assemble into flat lamella structures associated with the ER ([@bib0329]). One explanation for a failure to achieve curvature is that high levels of 2a^pol^ may interfere with this hexamer to pentamer transition. This is supported by the observation that when domains that allow association of 1a and 2a^pol^ are deleted, the 2a^pol^ is unable to alter the structure of spherules formed by 1a. The correct ratio of 1a and 2a^pol^ is clearly important for replication complex assembly and may be maintained during infection through inhibition of translation initiation of the 2a RNA.

D. The Flaviviridae replicate in vesicular packets and membraneous webs {#sec0017}
-----------------------------------------------------------------------

### 1. The Flavivirus Replicase {#sec0018}

In the Flaviviridae family, which includes the *Flavivirus*, *Pestivirus*, and *Hepacivirus* genera, the RNA genome encodes a polyprotein precursor that is cleaved by viral proteases to produce structural proteins from the N‐terminal region. The replicase of the Flaviviridae is made from NSPs, NS5A, NS5B, NS4B, and NS3--4A, found at the C‐terminus. With the exception of the polytopic NS4B membrane protein, which is inserted cotranslationally into the ER, the membrane‐anchored components of the complex are inserted into the cytoplasmic face of the ER after translation ([Fig. 1](#fig0001){ref-type="fig"}B). The NS5B is the RdRp, and a C‐terminal stretch of 21 hydrophobic amino acids directs NS5B to the cytoplasmic face of the ER ([@bib0098], [@bib0230]). The NS3 protein has NTPase/helicase activity. NS3 is not a membrane protein but is recruited to the complex through association with membrane‐anchored NS4A. NS5A is also membrane associated, and association is mediated via 31 amino acids at the N‐terminus that form an amphipathic α‐helix ([@bib0037], [@bib0107]).

### 2. Membranes used for flavivirus replication are provided by the *trans*‐Golgi network {#sec0019}

Replication of flaviviruses (e.g., Dengue, West Nile, and Yellow Fever viruses) takes place in membrane invaginations. For historical reasons, these are called vesicular packets \[reviewed in [@bib0199]\]. They are larger (80‐ to 100‐nm diameter) than the 50‐nm alphavirus spherules, and form from the limiting membrane of the *trans*‐Golgi network (TGN) ([@bib0367], [@bib0386]). Infection by Kunjin virus leads to unique membrane structures thought to be derived from both the early and late secretory pathways. These include convoluted membranes and paracrystalline arrays derived from the rough ER and ERGIC, and vesicle packets derived from the TGN ([@bib0202], [@bib0252], [@bib0309], [@bib0386]). The detection of dsRNA and viral NSPs (NS1, NS2A, NS3, and NS4A) within the vesicle packets points strongly to this being the site of RNA replication ([@bib0201], [@bib0386]). The vesicle packets associate closely with the convoluted membranes and paracrystalline arrays, which are thought to be the sites of proteolytic processing of NS3 and NS2B ([@bib0386]). These modified membranes are linked with the ER, and ultrastructural studies have shown virions present in the ER, cytoplasmic vesicles, Golgi cisternae, and vacuoles. The results suggest that membranes containing the spherules responsible for replication may become associated with the ER to facilitate delivery of genomes to viruses, budding into early compartments of the secretory pathway ([@bib0200]).

### 3. Hepacivirus replication occurs in association with the ER {#sec0020}

*Hepatitis C virus* (HCV) is closely related to the flaviviruses, and its importance as a human pathogen has generated great interest in its mechanism of replication. Until, recently infection models have not been available to study the replication complex of HCV, and the studies discussed here have focussed on the expression of the entire polyprotein from replicons ([@bib0103], [@bib0135]). However, the recent production of a HCV that replicates efficiently both *in vivo* and in cell culture ([@bib9001], [@bib9003], [@bib9013]) will expand the possibilities for studying and understanding the viral replication cycle. HCV replication is thought to occur on membranes derived from the ER as all studies of NSPs have found them localized to this organelle ([@bib0098], [@bib0154], [@bib0172], [@bib0395]). Studies have also identified a "membraneous web" of membrane vesicles of ∼85‐nm diameter associated with the ER and a population of irregular double‐membraned vesicles. The web resembled the "sponge‐like inclusions" seen in the liver of chimpanzees infected with HCV, suggesting it is physiologically relevant. Interestingly, the great majority of the NSP synthesized by full--length genomes or subgenomic replicons may not be involved in RNA replication ([@bib0288]). The bulk of the NSPs associated with membranes isolated from cells expressing replicons is sensitive to protease, while *in vitro* replicase activity is resistant to protease and nuclease activity ([@bib0106], [@bib0288]). The results suggest that replication of HCV takes place within membrane vesicles, rather than on the surface of the membraneous web. These vesicles may be associated with the membraneous web, but the similarity between HCV and the flaviviruses leaves open the possibility that the membrane invaginations responsible for replication may also form in the TGN but be closely associated with the ER.

### 4. Flavivirus nonstructural proteins can induce membrane rearrangements {#sec0021}

Studies have investigated which viral proteins are responsible for membrane rearrangements seen in cells infected with flaviviruses. The NS4A of Kunjin virus induces the characteristic convoluted membranes and paracrystalline arrays seen in flavivirus infections. The NS4A‐B protein also causes membrane rearrangement, but the highly condensed structures seen in infected cells are not produced until the NS2B‐3 protease cleaves NS4A free from NS4B ([@bib0309]). The NS4B then translocates to the nucleus ([@bib0385]). Interestingly, this contrasts with HCV where NS4B (and NS4A‐B) ([@bib0103], [@bib0177]) rather than NS4A is able to induce the membranous structures.

### 5. Flaviviruses can modulate the secretory pathway {#sec0022}

Flaviviruses have been found to upregulate cell surface expression of MHC class I and II in response to interferon ([@bib0173], [@bib0191], [@bib0193]). This is not caused by effects of the NS4A or NS4B proteins on membrane traffic; instead flavivirus infection increases expression of the ER peptide transporter, TAP1. This increases the supply of peptides that are necessary for the folding and export of newly synthesized MHC proteins from the ER. Increased TAP expression is mediated by increased transcriptional activity of p53 and can be induced in liver HepG2 cells by expression of the HCV core/capsid protein alone ([@bib0146], [@bib0227]).

While the capsid/core protein is able to increase cell surface expression of MHC class I through increase expression of TAP1, expression of the HCV polyprotein has been shown to slow the movement of proteins through the secretory pathway of host cells ([@bib0177]). The rate of delivery of MHC class I to the plasma membrane in cells infected with HCV was reduced three‐ to fivefold relative to cured control cells. Expression of the precursor NS4A‐B was found to reduce ER‐to‐Golgi traffic two‐ to threefold ([@bib0177]), while the other NS proteins of HCV including NS4A and NS4B, individually or combined, were unable to interfere with the trafficking pathway. NS4B alone induces a membraneous web in cells ([@bib0103]), and both NS4A‐B and NS4B induce, and locate to, clustered and aggregated membranes looking very similar to the membraneous web seen in cells expressing replicons. In addition to aggregated membranes, NS4A/B also induces, but does not colocalize with, swollen vesicular structures. Theses swollen vesicles have a similar morphology to the vesicles induced by the 3A protein of *Poliovirus*, which swells ER membranes and blocks secretion between the ER and the Golgi apparatus ([@bib0092]). [@bib0177]) hypothesize that the NS4A/B could be functioning in a similar manner to *Poliovirus* 3A.

E. The Nidovirales replicate in association with double‐membraned vesicles {#sec0023}
--------------------------------------------------------------------------

### 1. The Nidovirus replicase is generated from two polyproteins {#sec0024}

The Nidovirales order comprises the Arteriviridae, Coronaviridae, and Roniviridae families. The replicase gene is composed of two open reading frames termed ORF1a and ORF1b. ORF1b is generated from a frameshift in 1a, and both reading frames encode complex polyproteins processed by viral proteases ([@bib0133], [@bib0404]). The arterivirus ORF1b encodes NSPs 9--12, including the RdRp (NSP9) and helicase (NSP10). The ORF1b, however, lacks hydrophobic domains able to target the replicase to membranes. Interestingly, the hydrophobic domains necessary for membrane targeting are encoded by ORF1a in NSP2, 3, and 5, suggesting that ORF1a proteins produce a scaffold to locate the viral replication--transcription complex to membranes ([Fig. 1](#fig0001){ref-type="fig"}D) ([@bib0267], [@bib0370]). A similar strategy is used by CoV, for example mouse hepatitis virus (MHV) and severe acute respiratory syndrome‐CoV (SARS‐CoV) ([@bib0275], [@bib0276]), where transmembrane domains are located in NSP3, 4, and 6, and helicase and polymerase proteins are NSP12 and 13, respectively, and NSP16 encodes the methytransferase. The Nidovirales have the largest coding capacity of the single‐stranded RNA viruses, and not all the 16 NSPs have been studied in detail. It is possible that other proteins encoded by ORFs1a and 1b, such as RNA processing enzymes, are incorporated into the replication complex.

### 2. Sites of arterivirus and CoV replication are separate from sites of envelopment and budding {#sec0025}

Several studies have investigated the intracellular sites of replication of equine arterivirus (EAV), MHV, and SARS‐CoV. Such studies are difficult because during nidovirus infection, the processes of replication and envelopment occur on different membranes, and these may merge during encapsidation. Furthermore, late during infection cells infected with MHV can form syncitia. Newly synthesized MHV viral RNA has been found in perinuclear sites colocalized with the RdRp ([@bib0332]), and depending on whether human or murine cells were infected, these sites colocalized with Golgi or ER membranes, respectively. Similar studies in mouse L cells report that the polymerase and newly synthesized RNA locate to late endosomes and endocytic carrier vesicles ([@bib0371]). This discrepancy is in part reconciled by later work showing that the subcellular distribution of the replicase proteins can change during the course of infection, since replicase proteins move to sites of envelopment in the ERGIC ([@bib0036]). This is supported by the finding that individual replicase proteins distribute differently following cell membrane fractionation ([@bib0340]). Membrane fractionation has also been carried out by [@bib0134], who showed that several proteins encoded by ORF1a and b were associated with membranes, and when observed by immunogold electron microscopy, these were associated with rosettes of double‐membraned vesicles 200--350 nm in diameter. The role of these vesicles in viral RNA replication was confirmed by *in situ* hybridization of labeled riboprobes. Double‐membraned vesicles are also seen in cells infected with EAV ([@bib0267]). EAV replicase proteins accumulate in perinuclear regions containing ERGIC and ER markers and colocalize with newly synthesized viral RNA, again suggesting sites of genome replication. Notably, similar structures can be produced by expression of arterivirus ORF1a‐encoded proteins NSP2--7, which contain the membrane proteins thought to tether the replicase to membranes.

### 3. The double‐membraned vesicles induced by arteriviruses and CoVs may be related to autophagosomes {#sec0026}

Double‐membraned vesicles are usually rare in cells but are induced during autophagy. A role for autophagy during MHV infection is suggested because autophagy is induced in cells infected with MHV. Furthermore, in cells lacking Atg5, a protein required for the formation of autophagosomes, there is a 99% reduction in virus yield and MHV fails to induce double‐membraned vesicles ([@bib0275]). Electron micrographs show that the double‐membraned vesicles induced by SARS‐CoV extend from the ER and can be labeled with antibodies specific for replicase proteins. This suggests that, in common with MHV, the vesicles are a site of replication ([@bib0342]). Even though all SARS‐CoV replicase proteins tested colocalize to punctate structures that accumulate near the nucleus, there are conflicting reports about their relationship with autophagosomes. In monkey Vero cells, the replicase proteins colocalize with autophagosomes identified using antibodies against LC3 ([@bib0275]). However, when autophagosomes are identified by expression of GFP‐LC3, the replicase proteins do not colocalize with the GFP signal ([@bib0342]). The vesicles induced by SARS‐CoV are smaller at 100‐ to 300‐nm diameter than autophagosomes (500--1000 nm) and are labeled with ER markers. This has lead Snijder and colleagues to suggest that they are virus‐induced extensions to the ER, rather than *bona fide* autophagosomes ([@bib0267], [@bib0342]). The precise origins of the membrane crescents that form at the start of autophagy are unclear, and a number of studies have suggested they may form from the ER. This makes it possible that the double‐membraned structures may be autophagosomes that have been modified by an accumulation of viral protein. Determining if autophagy is beneficial to SARS‐CoV replication will have to await studies in cells where key proteins in the autophagy pathway have been removed or suppressed by gene silencing.

IV. Virus Factories and Inclusion Bodies Generated by Large DNA Viruses {#sec0027}
=======================================================================

A. Cytoplasmic virus factories formed by large cytoplasmic DNA viruses {#sec0028}
----------------------------------------------------------------------

The asfiviruses, poxviruses, iridoviruses, and the phycodnaviruses are large DNA viruses encoding hundreds of proteins from genomes ranging between 150 and 350 kbp. A comparison of protein sequences encoded by these viruses has suggested that they should be grouped together in a family of viruses called the *n*ucleo*c*ytoplasmic *l*arge *D*NA *v*iruses (NCLDV) ([@bib0162]). Sequence similarities are seen in the major capsid proteins, redox enzymes that maintain disulphide bonds in the cytosol, and proteins that regulate apoptosis; and the family has been extended to include the giant mimivirus isolated from the ameba *Acanthamoeba polyphaga* ([@bib0182]). Even though these viruses infect a diverse range of hosts from different phyla, including vertebrates \[poxviruses, *African swine fever virus* (ASFV)\], arthropods (entomopox, ASFV, chloriridoviruses), amphibians and fish (*Ranavirus*, *Megalocytivirus*, and *Lymphocystivirus* genera of the Iridoviridae family), marine algae (phycodnaviruses), and protozoa (mimivirus), they all generate cytoplasmic factories as major sites of virus assembly and replication (illustrated in [Fig. 4](#fig0004){ref-type="fig"} ). The factories share many similarities with one another, again suggesting that this diverse group of viruses may be related and that the need to produce a virus factory in the cytoplasm was generated early in virus evolution.Figure 4Schematics of inclusions induced during virus infection. ASFV induces single large perinuclear factories surrounded by mitochondria. *Vaccinia virus* induces multiple factories derived from membrane‐enclosed replication complexes (RC) both of which are associated with mitochondria. Certain poxviruses also induces electron‐dense A‐type inclusions (A). Human herpesvirus 1 induces capsid assembly sites, or assemblons (As), replication compartments (RC), inclusions of tegument proteins VP13/14 and VP22 (VP), and electron‐dense bodies of UL11 and UL12 gene products (11 and 12) in the nucleus. Human herpesvirus 2 also induces nuclear inclusions of UL55 gene product (55) and human herpesvirus 6 induces nuclear tegusomes (T). Herpesviruses induce cytoplasmic assembly sites where envelopment and some tegument are acquired (Env) in human herpesvirus 5, these sites include electron‐dense bodies (DB). Iridoviruses induce multiple cytoplasmic virus factories (VF) and crystalline arrays (CA), both of which associate with mitochondria. Reoviruses also induce multiple cytoplasmic virus factories (VF) and crystalline arrays (CA) that are enclosed within lysosomal membranes.

### 1. ASFV factories form next to the microtubule organizing center {#sec0029}

ASFV is the sole member of the *Asfivirus* genus, family Asfarviridae but shares striking icosahedral similarity with the iridoviruses, phycodnaviruses, and mimivirus. ASFV is a large double‐stranded DNA (dsDNA) virus with a genome size ranging from 170 to 190 kbp. Gene expression is a regulated cascade and immediate early, early, early/late, intermediate, and true late gene types have been characterized to date. The virion has multiple concentric layers with an electron‐dense core at the center that contains the viral genome. A protein matrix surrounds the core, which in turn is enclosed by a lipid bilayer. Finally, the bilayer is surrounded by a protein capsid layer. ASFV can gain a third envelope when it buds from the plasma membrane at the tip of actin‐rich projections that resemble filopodia ([@bib0168]). ASFV probably enters cells by receptor‐mediated endocytosis, but the steps following entry are poorly understood. It is possible that a viral core is delivered into the cytoplasm intact; alternatively, cores may dissociate in endosomes requiring some mechanism of genome delivery across the endosome membrane. Genome replication occurs both in the nucleus and cytoplasmic factories. Transfer to the nucleus may involve microtubule transport since late gene expression is inhibited by agents that depolymerize microtubules and the dominant‐negative dynein motor protein p50‐dynamitin ([@bib0006], [@bib0143]). ASFV does not produce nuclear inclusions analogous to those seen in herpesvirus and adenovirus infection, but there is evidence that small fragments of viral DNA are synthesized in the nucleus. The major site of ASFV DNA replication is, however, the virus factory ([@bib0307]).

#### a. Cytoplasmic factories formed during ASFV infection are assembled at the microtubule organizing center {#sec0030}

ASFV induces one principal factory in the cytoplasm during infection. Electron microscopy shows that the virus factory excludes obvious cellular organelles and contains mostly viral DNA, viral proteins, virus‐induced membranes, and partially and fully assembled virions ([Table I](#tbl0001){ref-type="table"} ; [Fig. 5A](#fig0005){ref-type="fig"} ; [@bib0042], [@bib0235], [@bib0314]). The mechanisms that target viral proteins, virus‐induced membranes, and viral DNA to the ASFV factories are poorly understood. Immunofluorescence staining for viral structural proteins generally reveals a strong signal at the factory and a weaker signal in the cytoplasm. The B602Lp protein (CAP80), which is a viral chaperone involved in folding and membrane recruitment of the major capsid protein, p73, is, for example, absent from the virus factories ([@bib0069], [@bib0108]). This suggests that p73 is synthesized and folded in the cytoplasm and then recruited to factories. Similarly, the viral dUTPase, which is necessary for efficient replication, is excluded from the viral factory ([@bib0261]). Since the bulk of viral DNA synthesis occurs in the factory ([@bib0127]), it is not easy to explain how the viral dUTPase edits uracil from progeny viral genomes, without being present at the site of viral DNA synthesis and encapsidation. ASFV factories disperse when cells are incubated with drugs that depolymerize microtubules ([@bib0143]) suggesting their formation involves microtubule motors. This may involve dynein motor proteins since p50‐dynamitin, a dominant‐negative version of the dynein motor, prevents both late ASFV gene expression ([@bib0143]) and vimentin recruitment to factories (see below and [@bib0348]). Yeast‐two‐hybrid screens and *in vitro* pull‐down experiments show that one ASFV structural protein, p54/j13Lp, interacts with dynein ([@bib0006]). While direct binding of p54/j13Lp to the motor protein has not been observed in infected cells, it is possible that the protein is involved in transporting some viral proteins into factories. The protein locates to virus factories and deletion of the E183L gene encoding p54/j13Lp generates factories that lack viral membranes, the major capsid protein p73, and the polyprotein precursors (pp220, and pp62) of the viral matrix ([@bib0108], [@bib0301]). P54/j13Lp is a membrane protein with the bulk of the protein, including the dynein‐binding motif, exposed to the cytosol. The p73 capsid protein and pp220 polyprotein associate with membranes before assembly into viruses ([@bib0066], [@bib0067], [@bib0144]). If these membranes contain p54/j13Lp, it would provide a means of allowing recruitment to factories by retrograde transport along microtubules.Table IKnown contents of viral inclusions induced by different virus families. Each section includes a brief description of the viral inclusion and lists both viral and host-cell proteins confirmed to localize within, or associate with, the specified structure*Asfarviridae, Asfivirus African swine fever virus*References*Cytoplasmic virus factory***Appearance and contents of viral origin**[a](#tblfn0001){ref-type="table-fn"}Viral membranes, assembling and complete particles, electron dense condensations, viral DNA, A224L IAP apoptosis inhibitor, A104R (5AR) DNA binding histone like, A137R p11.5, B119L Erv1p homologue, B438L p49, B646L p73 major capsid protein, CP2475L pp220 precursor to p150; p37; p34 and p14 CP530R pp62 precursor to p35 and p15, O61R p12 attachment, D117L (i1L) transmembrane, S273R (i6R) cysteine protease, H108R (j5R) membrane, E183L p54 ( j13L) dynein interacting, E199L ( j18L) membrane, E120R (k3R) p14.5 DNA binding necessary for viral exit from factory[@bib0003], [@bib0006], [@bib0008], [@bib0010], [@bib0031], [@bib0043], [@bib0044], [@bib0052], [@bib0056], [@bib0067], [@bib0126], [@bib0127], [@bib0143], [@bib0150], [@bib0166], [@bib0167], [@bib0208], [@bib0235], [@bib0302], [@bib0314], [@bib0324], [@bib0339], [@bib0351], [@bib0374]**Contents of cellular origin**Ubiquitin, hsp70 chaperone, γ‐tubulin, Pericentrin, p21, mdm1 Surrounded by: ER membranes, vimentin, p230 Golgin, mitochondria, and tubulin.[@bib0137], [@bib0143], [@bib0150], [@bib0166], [@bib0247], [@bib0248], [@bib0306], [@bib0314], [@bib0348]Poxviridae, Chordopoxvirinae, *Orthopoxvirus Vaccinia virusCytoplasmic A‐type inclusion***Contents**[b](#tblfn0002){ref-type="table-fn"}Electron dense, IMV, A26L (WR148 and WR149) myristylated[@bib0265]*Cytoplasmic B‐type inclusion, virosome, or virus factory***Appearance and contents of viral origin**[b](#tblfn0002){ref-type="table-fn"}Electron dense viroplasm, viral crescents, IV and IMV, viral DNA, A2.5L (WR121) redox, A3L (WR122) p4b core, A4L (WR123) p39 core, A9L (WR128) membrane, A10L (WR129) p4a core, A11R (WR130) phosphoprotein, A13L (WR132) membrane ERGIC, A14L (WR133) membrane ERGIC, A14.5L (WR134) membrane virulence, A15L (WR135) viroplasm/membrane association, A16L (WR136) cell‐fusion/entry, A17L (WR137) membrane assembly, A18R (WR138), A30L (WR153) viroplasm/membrane association, A35R (WR158) virulence, A40R (WR165) SUMO‐1 modified, A45R (WR171) virion superoxide dismutase homologue, B1R (WR183) protein kinase, D4R (WR109) uracil DNA glycolase, D8L (WR113) p32, D13L (WR118) p65 scaffold, E3L (WR059) dsRNA binding E5R (WR061) E8R (WR064) ER protein, surrounds virosome E10R (WR066), F10L (WR049) protein kinase viroplasm/membrane association, F17R (WR056) actin tail formation G7L (WR085) viroplasm/membrane association, H3L (WR101) p35 core membrane, H5R (WR103) transcription factor VLTF‐4, I3L (WR072) ssDNA binding, I4L (WR073) ribonucleotide reducatase large subunit, J1R (WR093) core viroplasm/membrane association, L1R (WR088) myristylated, L4R (WR091) p25K core; ssDNA/ssRNA binding, Ectromelia zinc finger binding protein (absent in Copenhagen, fragment in WR), Cowpox CP77 host range factor, WR011 E3‐ubiquitin ligase.[@bib0005], [@bib0019], [@bib0027], [@bib0063], [@bib0076], [@bib0077], [@bib0084], [@bib0087], [@bib0094], [@bib0180], [@bib0237], [@bib0246], [@bib0260], [@bib0263], [@bib0268], [@bib0291], [@bib0296], [@bib0297], [@bib0310], [@bib0316], [@bib0330], [@bib0344], [@bib0354], [@bib0355], [@bib0356], [@bib0363], [@bib0373], [@bib0381], [@bib0394], [@bib0398], [@bib0401]**Contents of cellular origin**HMG20A viral genome binding protein, hSP90; transient association, Ubiquitin, ying‐yang 1 transcription factor, TBP transcription factor, SP1 transcription factor, RNA polymerase II, SUMO‐1, ERGIC‐53[c](#tblfn0003){ref-type="table-fn"} Surrounded by: vimentin and mitochondria.[@bib0045], [@bib0080], [@bib0152], [@bib0155], [@bib0156], [@bib0246], [@bib0259], [@bib0263], [@bib0298], [@bib0391]Iridoviridae, *RanavirusCytoplasmic virus factories***Appearance and contents**[f](#tblfn0006){ref-type="table-fn"}Electron lucent, virus, viral DNA, 108K early protein, 57K, 55K major capsid protein (ORF 90R in FV3), 38K, 17K, 16K *Rana grylio* virus dUTPase (ORF 63R in FV3). Surrounded by vimentin, rough ER, mitochondria and polysomes.[@bib0062], [@bib0083], [@bib0153], [@bib0239], [@bib0240], [@bib0402]Herpesviridae, *alphaherpesvirinae, simplexvirus* and *varicellovirusNuclear replication compartment***Contents of viral origin**[d](#tblfn0004){ref-type="table-fn"}UL3, UL4 virion, UL5 helicase‐primase, UL6 DNA cleavage/packaging, UL8 helicase‐primase, UL15 DNA packaging, UL17 tegument DNA packaging, UL18 DNA packaging, UL19 ICP5 major capsid protein, UL26.5 ICP35 DNA packaging, UL29 ICP8 single strand binding UL30 DNA polymerase, UL32 DNA packaging, UL33 DNA packaging, UL35 VP26 p12 capsid, UL42 65K DNA polymerase accessory, UL49 VP22 tegument, UL52 helicase‐primase UL54 ICP27 regulatory, α0 UL57 ICP0 transactivator, α4 ICP4 regulatory, α22 US1 ICP22 regulatory, US1.5 truncated, US1 regulatory.[@bib9004], [@bib0086], [@bib0112], [@bib9005], [@bib9006], [@bib0175], [@bib0184], [@bib0187], [@bib9007], [@bib9008], [@bib9010], [@bib0289], [@bib9011], [@bib0358]; Ward *et al*., 1996**Contents of cellular origin**RNA polymerase II, EAP ribosome component, proliferating cell antigen, retinoblastoma protein, p53, DNA ligase 1, DNA polymerase α, promyelocytic leukemia (PML), DNA‐PKcs, Ku86 nonhomologous end joining, Bloom syndrome gene product, breast cancer‐associated gene 1 protein, MSH2, Rad50, WRN RecQ helicase family member, BRG1 or BRM‐associated factor 155, brahma‐related gene‐1 protein, brahma protein, histone deacetylase 2, hSNF2H, mSin3a, TATA binding protein (TBP), TBP‐associated factors.[@bib0187], [@bib0196], [@bib0287], [@bib0359], [@bib0387]*Nuclear sites of capsid assembly or assemblons***Contents of viral origin**[d](#tblfn0004){ref-type="table-fn"}UL7 (HHV‐2), UL14 (HHV‐2) tegument, UL16 capsid, UL19 ICP5 major capsid protein, UL26.5 ICP35 DNA packaging, UL27 DNA packaging, UL35 VP26 p12 capsid, UL38 VP19c capsid assembly, UL43.5, UL55.de Bruyn Kops *et al*., 1998; [@bib0136], [@bib0243], [@bib9009], [@bib9012], [@bib0377], [@bib0378], [@bib0397]**Contents of cellular origin**Actin, myosin 5a actin motor[@bib0118]*Cytoplasmic assembly and envelopment site***Contents of viral origin**[d](#tblfn0004){ref-type="table-fn"}Membranes, vacuoles, capsids and enveloped virus UL19 (HHV‐2) VP5 major capsid protein UL27 (HHV‐2) gB VP7 UL36 (HHV‐2) ICP1--2, tegument UL46 (HHV‐2) tegument, UL48 (HHV‐2) tegument[@bib0170], [@bib0236], [@bib0257], [@bib0380]**Contents of cellular origin**Mitochondria, γ‐tubulin, hsp40 chaperone, hsp70 chaperone, GM130 Golgi marker[@bib0236], [@bib0257]Herpesviridae, Betaherpesvirinae, *Cytomegalovirus* Human herpesvirus 5*Cytoplasmic assembly sites***Appearance and contents**[e](#tblfn0005){ref-type="table-fn"}Membranes, vacuoles, capsids, enveloped virus and dense bodies (see below) UL23 tegument, UL24 tegument, UL25, UL32 pp150, UL43 tegument, UL53, UL55 gB, UL73 gN, UL75 gH, UL80 p38, UL83 pp65--69 UL99 pp28, gp65.[@bib0001], [@bib0018], [@bib0079], [@bib0185], [@bib0272], [@bib0320]*Cytoplasmic dense bodies***Appearance and contents**[e](#tblfn0005){ref-type="table-fn"}Homogenous electron dense material, UL73 gN, UL83 p65--69.[@bib0072], [@bib0272]Herpesviridae, Betaherpesvirinae, *Roseolovirus* Human herpesvirus 6*Nuclear/cytoplasmic tegusome***Appearance**Enveloped nucleocapsids, virus with tegument in cytoplasmic invagination of nucleus[@bib0303]Adenoviridae, *MastadenovirusNuclear small fibrillar masses, ssDNA accumulation sites or early replicative sites***Appearance and contents**Viral ssDNA replication, 72kDa ssDNA binding protein, viral RNA (early)[@bib0282], [@bib0283]*Nuclear fibrillogranular matrix or peripheral replicative sites***Appearance and contents**Viral RNA (late), E1A oncogenic proteins, E4‐ORF3, 72kDa ssDNA‐binding protein, DNA polymerase, terminal protein, PML, splicesomes, sp100, hsp70, nuclear factor 1[@bib0035], [@bib0054], [@bib0242], [@bib0279], [@bib0284]*Nuclear virus‐induced compact ring***Appearance and contents**Viral RNA (late), pIVa2 DNA packaging[@bib0197]*Nuclear clear amorphous inclusion***Appearance and contents**pIX, PML, PKR, CK2α[@bib0197], [@bib0311], [@bib0312], [@bib0346]*Nuclear electron‐translucent area***Appearance and contents**Virus, protein crystals, pentons, hexons, fiber protein, pIX, L1 52 kDa, L1 55 kDa, PML, PKR, CK2β[@bib0285], [@bib0286], [@bib0346]*Other pIVa2 positive nuclear structures induced during adenovirus 5 infection***Name**Nuclear irregular electron‐dense amorphous inclusion, Nuclear regular electron‐dense amorphous inclusion, nucleolus electron‐dense virus‐induced globules, nucleous irregular amorphous inclusion.[@bib0197]Reoviridae, *OrthoreovirusCytoplasmic virus factories***Appearance and contents**Filamentous or globular dependent on μ2, phase and electron dense, viral RNA, virus, σNS nonstructural, μ1 outer‐capsid, μ2 nonstructural, μNS nonstructural, λ1 core surface, λ2 core surface, λ3 RNA polymerase, σ2 core surface, σ3 structural, ubiquitin, microtubules, vimentin (association with).[@bib0020], [@bib0021], [@bib0040], [@bib0055], [@bib0082], [@bib0221], [@bib0331], [@bib0336]Reoviridae, *rotavirusCytoplasmic virus factories***Appearance and contents**Electron‐dense viroplasm, assembling and complete double‐shelled particles VP2, VP6, VP9, NSP2, NSP5, NSP6[@bib0007], [@bib0130], [@bib0270], [@bib0271], [@bib0337], [@bib0338][^1][^2][^3][^4][^5][^6]Figure 5(A) Electron micrograph of an ASFV factory showing partially assembled, empty and fully mature capsids as well as electron‐dense viroplasm accumulating around viral membranes. Image courtesy of P. Hawes, J. Simpson, and P. Monaghan, Bioimaging Group, IAH‐Pirbright. (B) Confocal micrograph of ASFV‐infected cells immunolabeled with antimajor capsid protein (green) and vimentin (red) and stained with a DNA dye (blue). Note vimentin cages enclosing ASFV factories. Reprinted from [@bib0228] with permission from Blackwell Publishing, Inc.

#### b. ASFV factories recruit intermediate filaments and resemble aggresomes {#sec0031}

The formation and morphology of ASFV factories closely resemble the formation of aggresomes ([@bib0143]), a cellular response to accumulation of misfolded protein aggregates ([@bib0165]). Aggresomes are microtubule‐dependent inclusions containing protein aggregates that form next to the microtubule‐organizing center (MTOC). Aggresomes recruit cellular components needed to deal with the problems associated with a buildup of aggregated misfolded protein. These include cellular chaperones and proteasomes to facilitate protein folding and/or degradation and mitochondria that may provide the ATP required for folding and proteolysis. The most striking structural changes seen during aggresome formation are the collapse of the intermediate filament protein, vimentin, into a cage surrounding the protein aggregates and the gross fragmentation of the Golgi apparatus. ASFV factory formation shows many similarities with this response to protein aggregation. Factory formation is preceded by clearance of cytoplasmic proteins from perinuclear areas around the MTOC. Vimentin then concentrates at the MTOC where it forms an aster aligned along microtubules ([@bib0348]). Following the onset of virus DNA replication and synthesis of late structural proteins, the vimentin aster is rearranged into a cage around the factory ([Fig. 5B](#fig0005){ref-type="fig"}; [@bib0143], [@bib0228], [@bib0348]). During this period, mitochondria and cellular chaperones are recruited to the factory ([@bib0143], [@bib0306]). Formation of vimentin cages in ASFV‐infected cells is linked to phosphorylation of vimentin at serine 82 by calcium calmodulin‐dependent protein kinase II (CamKinase II) ([@bib0348]), and drugs that inhibit CamKinase II activity block late gene expression and vimentin rearrangement. As will be discussed for poxviruses and iridoviruses, the vimentin cage may form a physical scaffold within the factory, or act as a cage to prevent movement of viral components into the cytoplasm. Chaperones recruited to the factory may facilitate folding of viral structural proteins during assembly, as has been shown for other viruses. The proximity of mitochondria to viral factories may provide the ATP that is required for ASFV assembly ([@bib0068]) or be indicative of an antiviral response as mitochondria are effectors of apoptosis. Taken together these results suggest that a cellular response originally designed to deal with the buildup of protein aggregates in cells is used by ASFV to generate a site specialized for virus assembly. As will be described later, similarities between aggresomes and virus assembly sites are also seen for the iridoviruses and poxviruses.

Following the onset of ASFV DNA replication, the microtubule network becomes disorganized. Microtubules are partially excluded from virus factories and form bundles and concentric rings in the cytoplasm ([@bib0166]). ASFV infection leads to disassembly of γ‐tubulin and pericentrin from the centrosome, and the centrosome becomes less able to nucleate microtubules. At the same time microtubules are stabilized by acetylation ([@bib0167]). Since pericentrin and γ‐tubulin play key roles in microtubule organization and nucleation at the MTOC, their loss from the centrosome, coupled with acetlylation of tubulin, may explain the rearrangement of microtubules induced by ASFV. The reasons for these profound effects on microtubules are not known but they may facilitate disruption of the virus factory allowing release of assembled viruses into the cytoplasm.

#### c. Membrane rearrangements caused by ASFV infection perturb the secretory pathway {#sec0032}

Current models for ASFV envelopment in virus factories predict that viral membranes are obtained from the ER. The major structural proteins are recruited from the cytoplasm onto the cytoplasmic face of the ER, and after which protein--protein interactions between these, and possibly viral proteins targeted to the ER lumen, lead to constriction of ER cisternae and clearance of host proteins from the ER lumen prior to envelopment ([@bib0009], [@bib0247], [@bib0248], [@bib0314]). This is consistent with low levels of ER proteins observed at ASFV assembly sites by immunoelectronmicroscopy ([@bib0314]) and standard fluorescence microscopy where ER proteins appear to be actively excluded from areas of viral replication ([@bib0009], [@bib0247]). In addition to effects on the ER, ASFV also affects the structure and function of later Golgi compartments of the secretory pathway ([@bib0213], [@bib0248]). Golgi structure is linked to microtubule organization and the changes seen during infection may in part be related to effects of ASFV infection on centrosome and microtubule function listed above. ASFV infection causes dispersal of ERGIC marker protein ERGIC‐53, the peripheral Golgi protein GM130, and late Golgi protein GalNac‐T2 transferase, suggesting disruption of ERGIC and Golgi membrane compartments. Most striking is the complete loss of the TGN. TGN loss is dependent on microtubules and involves dispersal of the TGN into separate vesicle populations containing either peripheral Golgi proteins or the integral membrane protein, TGN46. Not surprisingly, this dispersal slows the transport of proteins through the secretory pathway. ASFV slows the delivery of newly synthesized lysosomal enzymes to lysosomes ([@bib0213]), and in macrophages reduces transport of newly synthesized MHC class I to the plasma membrane ([@bib0248]). Thus, in common with picornaviruses, disruption of the secretory pathway by ASFV has the potential to slow the transport of important immunomodulatory proteins to the surface of infected cells and may mask them from immune surveillance.

### 2. Poxviruses generate virus factories and inclusions {#sec0033}

Poxviruses are large dsDNA viruses with genomes ranging from 130 to 375 kbp. Poxvirus gene expression follows the regulated cascade of other large dsDNA viruses with early, intermediate, and late transcripts described. Poxvirus progeny genomes are replicated exclusively in the cytoplasm in virus factories. The virus encodes all the enzymes necessary for transcription and replication of its genome. Genetic analysis has identified a minimum of five viral genes necessary for genome replication, these are A20R, B1R, D4R, D5R, and E9L encoding the DNA polymerase processivity factor, serine/threonine protein kinase, uracil DNA glycosylase, DNA‐independent nucleoside triphosphatase, and the DNA polymerase, respectively ([@bib0087], [@bib0109], [@bib0222], [@bib0278], [@bib0295], [@bib0347]). Only the product of the D4R gene, encoding the viral DNA glycosylase, has been confirmed to localize to the site of genome synthesis ([@bib0087]), and it would be interesting to discover the subcellular location of the other members of the minimum replicase. When viewed by electron microscopy, infectious virions have a striking brick‐shaped morphology, and different forms of virus are documented which vary in degree of complexity \[for review, see [@bib0070]\]. The interior of all poxvirus particles contains the virus core which houses the viral genome. Cores are enveloped in virus factories to produce the intracellular mature virus (IMV), which is fully infectious. Additional envelope layers gained at the TGN give rise to intracellular enveloped viruses (IEV), which after budding through the plasma membrane form cell‐associated and extracellular enveloped viruses (CEV and EEV). Poxviruses induce two principal inclusions during infection, the A‐type inclusion that is nonreplicative and the B‐type inclusion where virus replication and assembly occur in the virus factory ([Fig. 4](#fig0004){ref-type="fig"}; [@bib0169]).

#### a. Poxvirus A‐type inclusions contain the mature intracellular virus but not enveloped viruses {#sec0034}

A‐type inclusions are cytoplasmic bodies of dense homogeneous matter that contain mature virus particles and are studded with polyribosomes ([Fig. 6A](#fig0006){ref-type="fig"} ) ([@bib0158]). A‐type inclusions are extremely rare in vaccinia, variola, and rabbit pox infections but are prominent in cowpox, ectromelia, fowlpox, and canarypox infections where they are also referred to as Downie, Marchal, Bollinger, and Burnet bodies, respectively ([@bib0169]). The major component of A‐type inclusions is the product of the A26L gene or its equivalents. In vaccinia, A26 is truncated and produces a protein of 92--94 kDa whereas the full‐length gene in cowpox encodes a protein of 160 kDa ([@bib0265]), both versions are myristylated ([@bib0207]). Immunfluorescence analysis of cells infected with *Vaccinia virus* with antibodies raised against A26 does reveal multiple A‐type inclusions in the cytoplasm, but they are much smaller than those seen in cells infected with cowpox, and do not contain virus particles ([@bib0265]). In cells infected with wild‐type cowpox, only IMV particles were observed within A‐type inclusions, but treatment with rifampicin, a drug that blocks poxvirus maturation at an early stage in morphogenesis, caused aberrant immature virus particles to integrate into the inclusions ([@bib0158]). The factor necessary for occlusion of viral particles in A‐type inclusions has been identified as the 4c core protein ([@bib0214], [@bib0333], [@bib0368]). It has been hypothesized that 4c retains vaccinia virions within the cell as IMVs in A‐type inclusions preventing their transport to the TGN for envelopment and maturation to the IEV types of virion ([@bib0214]). A‐type inclusions are predicted to protect IMVs during transport between hosts akin to that of the polyhedra that occlude entomopox and baculoviruses ([@bib0305]). Therefore, EEVs may be important for cell‐to‐cell spread, while IMVs (whether occluded or not) may be more important for host‐to‐host spread ([@bib0214]).Figure 6(A) Electron micrograph of A‐type inclusions from cowpox‐infected cells, showing intracellular mature virus in electron‐dense inclusions (A) surrounded by polyribosomes (arrows). Reprinted from [@bib0158] with permission from Elsevier. (B and C) Electron micrographs of factories of recombinant *Vaccinia virus* encoding the A15L gene under the control of the lac operon under nonpermissive (B) and permissive (C) conditions. Note empty immature virus particles (IV), viral crescents in an electron‐lucent environment, and a separate homogenous viroplasm (VP) in panel B and compare to wild‐type like conditions in panel C, which include immature virus with electron‐dense centers and particles containing nucleoids (n). Reprinted from [@bib0354] with permission from Elsevier.

#### b. Poxvirus B‐type inclusions are factories and are the main sites of replication and assembly {#sec0035}

B‐type inclusions originally called Guarnieri bodies ([@bib0141]) are the primary replication centers of the poxviruses, now generally referred to as virosomes or virus factories ([Fig. 6C](#fig0006){ref-type="fig"}). Electron microscopic analysis of B‐type inclusions revealed a granular matrix that was denser than the surrounding cellular material and in a defined area of the cytoplasm called viroplasm ([@bib0080], [@bib0149]). The factories also contain viral crescents consisting of membrane and viral proteins associated with viroplasm, spherical immature virus, and IMVs ([@bib0080]). Factories are surrounded by mitochondria, increase in number and size during the replication cycle and can occupy the majority of the cytoplasm at late times of infection ([@bib0080]).

The assembly and envelopment of *Vaccinia virus* within virus factories has been the subject of many studies and is discussed in papers and reviews ([@bib0140], [@bib0147], [@bib0151], [@bib0343]). Here, we will review some of the early steps that lead up to the start of genome replication and factory production. These have also been described in a review ([@bib0327]). It is generally believed that infection results in the delivery of viral cores into the cytoplasm. Cores are seen associated with microtubules ([@bib0053], [@bib0205], [@bib0273]) and may use microtubules to reach perinuclear sites that will eventually house the virus factories. Viral cores can transcribe as many as 100 early mRNAs before the onset of DNA replication, and these early mRNAs appear in discrete foci that associate with microtubules, contain polyribosomes and other translational machinery. It is unlikely that foci involved in transcribing early RNAs mature into viral replication sites because they do not initiate DNA synthesis ([@bib0206]). It is likely that each infecting virus can induce its own replication center ([@bib0050]), but it is not clear where in the cell the cores initiate DNA synthesis. It has been suggested that the onset of DNA synthesis may occur at peripheral sites and therefore precedes delivery to the perinuclear region of the cell. When cells are incubated with hydroxyurea to prevent the onset of viral DNA replication, it is possible to localize viral DNA released into the cytoplasm. Under these conditions, viral genomes are seen at several discrete sites that contain B1 protein kinase, E8 membrane protein, I3 ssDNA‐binding protein, and H5 late transcription factor ([@bib0094], [@bib0381]). After removal of hydroxyurea, these foci begin to make new viral DNA, showing that they are sites of DNA replication. Live cell imaging studies have shown that these initial sites of DNA replication form in the cell periphery and then move toward the nucleus where they coalesce into large structures ([@bib0327]).

Electron micrographs suggest that sites of DNA release from cores are intimately associated with ER membranes and become completely enclosed by them during the initial stages of DNA replication ([@bib0206]). This process is likely facilitated by the E8R gene product which is a membrane protein localized to the ER and early Golgi membranes, has DNA‐binding activity, and is able to capture viral genomes ([@bib0093], [@bib0363]). These ER‐enclosed genomes are short‐lived structures because they are not seen once viral crescents, IV and IMVs, appear in factories ([@bib0363]). The sites of DNA replication are also separate from the foci involved in transcribing early RNAs, and it is interesting to consider how the cores are separated from newly transcribed RNA. Viral cores and sites of RNA transcription both align on microtubules and partially colocalize with the L4 core DNA‐binding protein ([@bib0205]). The L4 protein is able to bind microtubules ([@bib0273]) and may be involved in separating RNA from cores along microtubule tracks ([@bib0205]).

Inducible recombinants or temperature‐sensitive mutants grown under nonpermissive conditions can give further insight into the early stages of inclusion formation. Electron micrographic analysis of the factories formed under these conditions yield striking images of distinct inclusions of homogeneous electron‐dense viroplasm next to empty spherical immature virions ([Fig. 6B and C](#fig0006){ref-type="fig"}) ([@bib0352], [@bib0353], [@bib0354]). A seven‐protein complex comprising the gene products of the A15L, A30L, D2L, D3L, F10L G7L, and J1R open reading frames has been identified as being necessary for association of viral membranes with the viroplasm ([@bib0354]). Consistent with this role, all of these proteins are known to localize to the virus factory except D2 and D3 ([Table I](#tbl0001){ref-type="table"}); however, these have been identified as core proteins ([@bib0099]) so are likely to reside at viral assembly sites. Localization of D13L to the virus factory is sensitive to the antibiotic rifampicin ([@bib0223]), and treatment with this drug induces irregular shaped viral membranes instead of the well‐defined hemispherical viral crescents seen in natural infection ([@bib0232], [@bib0269]). Therefore, it was suggested that D13L may act as a scaffold on which the viral membrane is shaped, allowing correct association with the viroplasm ([@bib0226]). Deep etch electron microscopy has confirmed this role for D13L, as it forms the honeycomb lattice identified as the outer coat of the viral membrane of immature virions ([@bib0147], [@bib0357]). Interestingly, D13L shares a structural similarity with structural proteins from many other virus families, including those of the other large dsDNA viruses ([@bib0024]). It will be interesting to see if the structural similarities to D13L translate to functional similarities in the assembly strategies of other viruses.

#### c. Poxvirus infection recruits host proteins into factories and rearranges cellular organelles {#sec0036}

*Vaccinia virus* recruits a number of cellular proteins to the viral factory. Ying‐Yang 1 (YY1), TBP, SP1 transcription factors, and RNA polymerase II are recruited from the nucleus to the factory ([@bib0045], [@bib0259], [@bib0391]). YY1 is a nuclear transcription factor that can activate late viral promoters and although poxviruses encode most of the genes necessary for transcription, there is evidence that cellular factors may be required for intermediate and late gene expression ([@bib0183], [@bib0313], [@bib0396]). The function of the other transcription factors in viral replication is unknown. They may be necessary for viral transcription like YY1, or perhaps they are sequestered into the factory to divert them from their normal roles in the nucleus, or their presence may represent an antiviral response by the cell. The presence of RNA polymerase II in the viral factory is a surprise because the virus encodes its own RNA polymerase activity which accounts for at least 9 ORFs and ∼7% of the genome capacity \[Western Reserve (WR) strain\]. Another cellular protein recruited from the nucleus to the cytoplasm is the HMG20A protein. This protein can bind the viral genome and has been implicated in host range restriction of *Vaccinia virus* in Chinese hamster ovary cells ([@bib0152]). During unproductive infection by *Vaccinia virus*, HMG20A is recruited from the nucleus to the factory where it binds viral DNA. If the cowpox host range gene CP77 is artificially introduced into *Vaccinia virus* then CP77 also enters the virus factory and binds to HMG20A; the cellular protein then dissociates from the viral genome and replication proceeds ([@bib0152]).

As seen for iridovirus and ASFV replication sites, vaccinia factories are surrounded by a vimentin cage ([@bib0298], [@bib0325]) and recruit molecular chaperones ([@bib0155]), suggesting similarity with aggresomes. Many proteins targeted to aggresomes are ubiqutinated, and most poxviruses encode a RING protein that is both a functional ubiquitin ligase and a virulence factor ([@bib0246]). Exceptions to this are the two most common laboratory strains of vaccinia, Copenhagen and WR. The RING protein from the IHD‐W strain of vaccinia is capable of directing transfected tagged ubiquitin to WR virus factories ([@bib0246]); however, it is unknown if native ubiquitin is localized to WR factories. The product of the A40R gene of vaccinia is tagged with the ubiquitin‐like protein SUMO‐1, and this modification is necessary for A40 targeting to viral factories, where it associates with ER membranes and may play a role in the formation of I3 sites ([@bib0263]). It is not known if movement of SUMOlyated A40 and ubiquitinated protein is directed along microtubules in a manner analogous to HDAC6‐mediated targeting of misfolded proteins to aggresomes ([@bib0171]). As reported for ASFV (see above) and cells infected with herpes simplex virus ([@bib0015]), infection of cells with *Vaccinia virus* also leads to disruption of microtubule organization and centrosome function and dispersal of the Golgi apparatus ([@bib0273]). Whether these are bystander effects of the production of virus factories close to the centrosome or induced deliberately to facilitate virus egress is not known. IMV exit from the factory and transport to envelopment sites at the TGN is nonetheless dependent on microtubules ([@bib0321]) and has been reported to be dependent on the A4L and A27L gene products ([@bib0321], [@bib0375]). Following envelopment, the A35L and F12L gene products then regulate microtubule‐dependent movement of intracellular enveloped viruses from the TGN to the plasma membrane ([@bib0145], [@bib0376]).

### 3. The iridoviruses generate cytoplasmic factories and crystalline arrays {#sec0037}

#### a. Iridoviruses {#sec0038}

Iridoviruses are large dsDNA viruses with genomes ranging from 100 to 210 kbp in length encoding between 100 and 230 proteins ([@bib0389]). Much of the work on iridovirus replication has been carried out on the ranavirus frog virus 3 (FV3). FV3 genome synthesis occurs in the nucleus and cytoplasm. No nuclear inclusions have been reported during FV3 infection, and as such it is unclear how the nuclear replication stage is mediated. However, viral DNA is initially synthesized as units that are 1--2 genomes in length and then transported to the cytoplasm where multiple length concatemers are produced ([@bib0131]).

#### b. Cytoplasmic factories formed during iridovirus infection resemble aggresomes {#sec0039}

Infection induces two cytoplasmic inclusions. Viral factories form in the cytoplasm and become the major site of viral DNA replication. FV3 also induces large crystalline arrays of viral particles which give rise to the iridescent coloring of purified virus, and hosts, that are characteristic of iridovirus infections. Virus factories are electron lucent relative to the cytoplasm and contain viral membranes, partially assembled viruses, and are surrounded by rough ER membranes and polysomes. FV3 factories also resemble aggresomes since they recruit intermediate filaments ([Fig. 7A](#fig0007){ref-type="fig"} ) and mitochondria, some of which show signs of damage ([@bib0083], [@bib0138], [@bib0153], [@bib0364]). Crystalline arrays of virus are associated with virus factories and can induce nuclear deformations that lead to kidney‐shaped nuclei similar to those seen in ASFV infection ([Fig. 7B](#fig0007){ref-type="fig"}) and after aggresome formation ([@bib0083], [@bib0143], [@bib0165]). As seen for ASFV and poxviruses, the intermediate filament vimentin plays an important role in replication ([@bib0239]). Vimentin is phosphorylated during FV3 infection, prior to factory formation ([@bib0060], [@bib0390]), and temperature‐sensitive mutants that are unable to phosphorylate vimentin do not form vimentin cages and are unable to proceed to late gene expression. Drug treatment with taxol or colchicine ([@bib0241]) showed that recruitment of vimentin to assembly sites requires dynamic, but not polymerizing microtubules, and microinjection of anti‐vimentin antibody prevented recruitment of vimentin to factories. This allowed intrusion of cell components into assembly sites and reduced virus growth by 70--80% ([@bib0241]). Vimentin may therefore provide a scaffold for iridovirus replication, maintaining a barrier between the cytoplasm and the contents of the virus factory. Consistent with this hypothesis is the observation that during infection, polyribosomes and most newly synthesized viral proteins associate with intermediate filaments ([@bib0240]). FV3 factory formation may also be dependent on the early 108K protein, as it is recruited to factories in the absence of late protein synthesis ([@bib0062]).Figure 7(A) Confocal micrograph of frog virus 3‐infected cell showing relationship between the major capsid protein (red), vimentin (green), and DNA (blue). Note multiple viral inclusions in the cytoplasm, each associated with an individual vimentin cage. Authors own. (B) Electron micrograph of a frog virus 3‐infected cell showing two crystalline arrays that appear to induce a kidney‐shaped nucleus (N). Reprinted from [@bib0083] with permission from Elsevier.

### 4. Phycodnavirus and mimivirus replicate in cytoplasmic factories {#sec0040}

Phycodnaviruses and the recently described giant virus mimivirus ([@bib0182]) induce replication complexes in the cytoplasm of infected ameba ([@bib0215]). The factories of the phycodnavirus Paramecium bursaria Chlorella virus 1 (PBCV‐1) are electron translucent areas of the cytoplasm and contain viral membranes, electron‐dense viroplasm, and assembling viruses. Unlike many viral factories, a distinct order appears to be present in PBCV‐1 virosomes. The assembling viruses are arranged at the periphery of the virosome/factory, giving the appearance of a rosette ([@bib0215]). Phycodnavirus replication and factory formation are not affected by a wide range of pharmacological disruptors of the cytoskeleton, including microtubule depolymerization by nocodazole and taxol, and depolymerization of actin by cytochalasin D ([@bib0254]). In this way, they differ from factories formed by large DNA viruses such as ASFV, vaccinia, and FV3. The successful cultivation of algae in the laboratory has allowed studies of the intracellular sites of replication of large icosahedral MclaV‐1 and HincV‐1 viruses ([@bib0392], [@bib0393]). These viruses produce a latent infection that becomes apparent once the algae produce reproductive organs that become host to millions of virus particles. Replication of these viruses begins in the nucleus, but the first evidence for virus assembly is provided by the appearance of electron‐dense bodies next to the nucleus at sites of breakdown in the nuclear envelope. Infection leads to stacking of ER cisternae that may provide membranes for virus envelopment. The dense bodies remain next to the nucleus in large inclusions, and take on the angular shape characteristic of capsid assembly seen for iridoviruses and ASFV. The nucleus eventually disintegrates, and the virus factory occupies most of the cytoplasm.

V. Herpesviruses Induce Nuclear Inclusions and Cytoplasmic Assembly Sites {#sec0041}
=========================================================================

A. Herpesviruses {#sec0042}
----------------

Herpesviruses are large dsDNA viruses with genomes ranging in size from 120 to 250 kbp. Herpesvirus genes are expressed in a regulated cascade starting with the immediate early α genes, then early β genes, and finally two subsets of late γ genes, γ~1~ and γ~2~. Complete herpesvirus particles have four main layers, the core containing DNA, an icosahedral capsid, a poorly defined layer of protein called tegument, and finally the viral envelope containing several glycoproteins. Genome synthesis and packaging and capsid assembly occur in inclusions in the nucleus. Nucleocapsids then obtain tegument in either the nucleus or the cytoplasm, or both, and the viral envelope is acquired exclusively in the cytoplasm \[see [@bib0216], [@bib0218] for more thorough analysis\]. The transfer of virus from the nucleus to the cytoplasm and acquisition of tegument appears well defined for human herpesvirus 6 (HHV‐6) ([@bib0303]) but is controversial for the alphaherpesviruses ([@bib0051], [@bib0217]). The subcellular organization of herpesvirus replication complexes formed in the nucleus during the early stages of productive infection has been described in considerable detail. The inclusions function as sites of virus replication and contain the virally encoded proteins and host proteins needed for virus replication. Interestingly, nuclear inclusions formed during herpes virus replication also contain cellular proteins involved in the control of DNA damage and repair. These may be recruited into inclusions in response to virus genome replication, and whether they are beneficial or detrimental to virus replication is a subject of considerable interest \[reviewed by [@bib0111]\].

B. Herpesvirus replication generates inclusions in the nucleus {#sec0043}
--------------------------------------------------------------

Herpesviruses enter the cell by fusing their envelopes with the plasma membrane, whereon the naked nucleocapsids migrate to nuclear pores, possibly along microtubules ([@bib0139], [@bib0345]) \[reviewed by [@bib0341]\]. Nuclear inclusions housing herpesvirus DNA replication are globular and can occupy the majority of the nucleus ([@bib0085], [@bib0289], [@bib0360]). They are identified through the presence of the viral DNA‐binding protein encoded by the UL29 gene, which is also known as infected cell protein 8 (ICP8). A minimum set of seven genes, UL5, UL8, UL9, UL29, UL30, UL42, and UL52, has been identified as necessary for viral DNA replication ([@bib0057]). A plasmid transfection system has shown *in vitro* these can form globular nuclear compartments that are sites of 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation and visually are similar to those formed during infection ([@bib0195], [@bib0403]). Nuclear inclusions organizing viral DNA replication have been followed in real time by a recombinant virus expressing a GFP‐ICP8 fusion protein. Small inclusions merge with adjacent replication complexes and increase in size to form globular replication complexes, which eventually fill most of the nucleus ([@bib0289], [@bib0360]).

### 1. Nuclear inclusions associated with herpesvirus replication are linked to ND10/PML Bodies {#sec0044}

Replication compartments are formed from a number of different discrete foci that are induced early in infection and whose interrelatedness is not fully understood. The initial stages of productive herpesvirus infection are, however, intimately linked with nuclear structures called ND10 bodies (illustrated in [Fig. 8](#fig0008){ref-type="fig"} ) \[[@bib0161], [@bib0211], review by [@bib0032]\]. Live cell studies have shown that the immediate early regulatory protein ICP4, which binds viral DNA, forms discrete foci as early as 30‐min postinfection ([Fig. 8A](#fig0008){ref-type="fig"}). These initially appear close to the nuclear envelope, possibly at sites where the genome first enters the nucleus following capsid disassembly at nuclear pores ([@bib0113]), and are then seen throughout the nucleus ([@bib0115]). ICP4 foci are seen juxtaposed to the ND10 marker promyelocytic leukemia protein (PML) some 60-min later. The early and late regulatory protein ICP27 is recruited to ICP4 foci 2‐h postinfection and facilitates efficient early gene expression ([@bib0115]). During the same period, the immediate early regulatory protein, ICP0, colocalizes with ND10 bodies, some of which are likely juxtaposed to ICP4 bodies ([@bib0114]). ICP0 mediates the ubiquitin and/or SUMO‐1‐targeted proteasomal degradation of ND10 components ([@bib0059], [@bib0110], [@bib0112], [@bib0115]). Finally, parental genomes localize to ICP4 foci ([@bib0113]), and the ICP4 foci enlarge into structures that resemble early ICP8 replication compartments ([@bib0113], [@bib0114]). Formation of ICP8 replication compartments ([@bib0359]) is also known to involve redistribution of ND10 bodies ([@bib0048]). The relationship between the early ICP4 structures associated with parental genome and the later ICP8 compartments associated with replication and production of progeny genome is not clear; however, ICP4 and ICP8 both localize to late replication compartments ([@bib0175]). A description of the relative and temporal distribution of the two proteins at early times awaits live cell studies following both proteins simultaneously.Figure 8Schematic representing interaction of herpesvirus foci with ND10 bodies. (A) Cell expressing PML‐ECFP (green) and infected with human herpesvirus‐1‐encoding ICP4‐EYFP (red) 115‐min postinfection. Boxes show zoomed sections demonstrating juxtaposition of ND10 and ICP4 bodies early during virus infection. Reprinted from [@bib0114] with permission from American Society for Microbiology. (B) Cell infected with human herpesvirus 2 showing assemblons immunolabeled with ICP35 (red) and UL55 inclusions (green). Note juxtaposition of the two compartments. Reprinted from [@bib0397] with permission from Society for General Microbiology. (C) Electron micrograph of human herpesvirus 5‐infected cell showing a section of a cytoplasmic assembly site. Note complete virus particle within a vacuole in bottom left‐hand corner, dense bodies in center of image, including one budding into a membrane. Reprinted from Craighead *et al*. (1972) with permission from American Society for Microbiology. (D) Electron micrograph of a tegusome within a nucleus of a human herpesvirus‐6‐infected cell, note apparent continuity between tegusome and cytoplasm (arrowed). Reprinted from [@bib0303] with permission from American Society for Microbiology.

### 2. Nuclear inclusions also form as sites of herpesvirus assembly: The assemblon {#sec0045}

A second prominent nuclear inclusion induced by herpesvirus infection is the assemblon ([@bib0378]). This is the site where capsid proteins accumulate and assemble into nucleocapsids ([Fig. 8B](#fig0008){ref-type="fig"}). The assembly of herpesvirus nucleocapsids has been researched in great detail at the ultrastructural level facilitated by a cell‐free system for reconstituting the particles ([@bib0148], [@bib0249], [@bib0250]). The mature herpesvirus capsid is icosahedral with a *T* = 16 symmetry and is composed of 150 hexons and 11 pentons of the major capsid protein UL19. The place of the remaining penton is taken by a 12‐mer of the portal protein UL6, which by analogy with bacteriophage may be the site of genome entry. Nucleocapsids mature from fragile procapsids, through B capsids that lack DNA and contain the internal scaffold protein UL26.5, to C capsids that contain the viral genome.

The relationship between assemblons and sites of viral DNA replication has been a topic of some controversy as some reports show direct colocalization ([@bib0358]), whereas others have shown a proximity ([@bib0243], [@bib0378]), similar to that seen between ND10 bodies and ICP4 foci during the initial stages of infection. Clearly, the DNA has to reach the capsid in order to complete assembly, and it is likely that the different results are indicative of the dynamic interactions between different herpesvirus nuclear inclusions. The DNA cleavage and packaging proteins encoded by the UL17 and UL32 genes are required for colocalization of viral DNA and capsids ([@bib0184], [@bib0358]). Cells infected with a virus encoding a faulty UL32 gene exhibit nuclear localization of the capsid protein VP5 that is separate from replication sites ([@bib0184]). Similarly, in cells infected with mutants that lack functional UL17, the ICP8 protein fails to colocalize with ICP5 and ICP35 ([@bib0358]). Actin also plays an important role in the correct nuclear subcompartmentalization of viral proteins. Infection with HHV‐1[1](#fn0001){ref-type="fn"} or suid herpesvirus‐1[2](#fn0002){ref-type="fn"} causes actin filaments to assemble in the nucleus, prior to the accumulation of capsid proteins ([@bib0118]). Depolymerization of actin with latrunculin A inhibited correct nuclear compartmentalization of a representative capsid protein (VP26). VP26 colocalizes with the actin motor myosin Va ([@bib0118]), and capsid movement within the nucleus is inhibited by the myosin motor inhibitor 2,3‐butanedione monoxime ([@bib0121]). This suggests that the organization of nuclear inclusions involved in herpesvirus assembly is dependent on cellular actin filaments, and it will be interesting to see if the organization of inclusions housing viral DNA replication sites is similarly dependent.

Other inclusion bodies have been reported in the nucleus of cells infected with herpesvirus. The tegument proteins VP22 and VP13/14 localize to inclusion bodies that align closely but do not overlap ICP0/ND10/ICP8 pre‐replication complexes or assemblon inclusions ([@bib0157]). UL55 also localizes to structures that overlap but are distinct from assemblons and DNA replication complexes ([Fig. 8B](#fig0008){ref-type="fig"}) ([@bib0397]). UL11 localizes to type IV and type V intranuclear dense bodies as well as virions and cytoplasmic ribbon structures ([@bib0016]). The alkaline DNase encoded by the UL12 gene localizes to discrete electron‐dense bodies within the nucleus that also contain B‐36 nucleolar protein ([@bib0194], [@bib0280]). It is unknown whether these different structures are related to each other, whether they are homogenous accumulations of the individual herpesvirus protein(s), or if they are simply dead‐end accumulations of protein.

### 3. Nuclear inclusions contain both viral and host proteins {#sec0046}

A large number and variety of cellular proteins accumulate at nuclear sites of herpesvirus replication and assembly. A comprehensive proteomic analysis of ICP8 interacting proteins revealed more than 50 viral and cellular proteins that maybe recruited to DNA replication sites ([@bib0359]). A number of these interacting proteins were confirmed to localize to replication sites by microscopy experiments ([@bib0359]), and these as well as proteins identified in other studies ([@bib0187], [@bib0196], [@bib0287], [@bib0387]) reveal that at least 23 cellular proteins are known to localize to nuclear inclusions involved in DNA replication during herpesvirus infection ([Table I](#tbl0001){ref-type="table"}). The functions of these proteins span the expected functions of nuclear genes, including DNA replication, transcription, chromatin remodeling, DNA repair, recombination, and nonhomologous end joining. Of particular importance is the recruitment of RNA polymerase II, which is required to transcribe the viral genome. RNA polymerase II is phosphorylated during viral infection by ICP22 and ICP27, and the latter modification is required for targeting to replication complexes ([@bib0078]).

The role of all of these cellular genes in the viral replication cycle is poorly understood; however, cells deficient in WRN, a recQ helicase family member, produced reduced virus yields while cells lacking Ku86, part of a nonhomologous end‐joining protein complex, produced increased yields of virus ([@bib0359]). The implication therefore is that some cellular proteins may be actively recruited to replication complexes to aid viral replication, and some may be recruited by the cell as part of an antiviral response or sequestered by the virus in inclusions to subvert their antiviral nature. PML is induced by interferon, suggesting an antiviral role. Many of the genes shown to be required for recruitment of PML to viral pre‐replication sites are part of the minimal set of genes required to synthesize viral DNA. Recruitment of PML to viral replication sites is, for example, dependent on the viral DNA polymerase (UL30), the origin binding protein (UL9 gene) and the helicase--primase complex (UL5, UL8, and UL52) ([@bib0049]). Recent evidence has suggested that this may be the reason why ICP0 causes dispersal of PML early in infection. PML knockdown by short interfering RNAs (siRNA) facilitates productive replication of ICP0 null mutants of herpesvirus ([@bib0115], [@bib0116]); moreover, ICP0 null mutants are hypersensitive to interferon in a manner dependent on PML ([@bib0058]). This is of particular importance because ICP0 plays a role in determining whether herpesvirus induces a quiescent or a productive, lytic infection ([@bib0233]).

C. Cytoplasmic inclusions form during late stages of herpesvirus tegumentation: The cytoplasmic assembly compartment {#sec0047}
--------------------------------------------------------------------------------------------------------------------

The tegument layer of alphaherpesviruses is composed of at least 15 different proteins ([@bib0216]). US11, UL17, UL47, UL48, and UL49 are components of the tegument, and all are localized to the nucleus (if not exclusively) during the productive life cycle of the virus ([@bib0124], [@bib0157], [@bib0179], [@bib0308], [@bib0358]). UL48 may play a role in egress from the nucleus, though this has not been unequivocally established ([@bib0234]). Therefore, it is likely that some tegument proteins are acquired in or during viral egress from the nuclear inclusions. Recently, cytoplasmic aggresome‐like structures have been described in cells infected with HHV‐2.^1^ These contain the major capsid protein, tegument proteins, envelope glycoproteins, and markers for the Golgi complex ([@bib0257]). The latter finding is particularly interesting because herpesvirus envelopment involves membranes from the TGN ([@bib0218], [@bib0366]). HHV‐5[3](#fn0003){ref-type="fn"} is a betaherpesvirus and late during infection produces a juxtanuclear "assembly compartment" that again contains tegument proteins (pp150, pp28, and pp68), the major capsid protein, and viral envelope proteins (gB, gH, and gp65), suggesting a cytoplasmic site specialized for tegumentation and envelopment ([Fig. 8C](#fig0008){ref-type="fig"}); ([@bib0001], [@bib0320]). The precise role of the cytoplasmic assembly compartment is unclear. On the one hand, the concentration of glycoproteins and tegument proteins in one site may facilitate final stages of assembly prior to release from the cell. Interestingly, in common with aggresomes induced by ASFV and misfolded proteins, the cytoplasmic assembly compartment recruits chaperones and mitochondria and is dependent on microtubules and localizes to the microtubule organizing center.

At present, the assembly compartments are not considered to be *bona fide* aggresomes because they are not surrounded by a collapsed cage of intermediate filaments ([@bib0257], [@bib0320]). It is nevertheless possible that these structures are related to aggresomes and are produced in response to a buildup of products resulting from nonproductive assembly pathways that occur late during infection. They may also contribute to the cytopathic effect seen in cells infected with HHV‐5. HHV‐5 infection results in cytomegaly characterized by increased cell size and intracellular water content. Cytomegaly and virus replication are both dependent on the presence of extracellular Na^+^, and infection results in sequestration of the plasma membrane Na‐K‐Cl‐cotransporter protein in large perinuclear structures that resemble the assembly compartment/viral aggresome ([@bib0204]). Electron‐dense bodies can be seen by electron microscopy within the cytoplasmic assembly compartments induced during HHV‐5 infection ([@bib0072]). Dense bodies are enveloped and obtain viral glycoproteins but do not contain DNA and are noninfectious. As can be seen in [Fig. 8C](#fig0008){ref-type="fig"}, dense bodies bud into membranes and appear as oversized enveloped viral particles without a DNA containing core. Dense bodies exit the cell to become extracellular dense bodies ([@bib0072]). Interestingly, HHV‐5 immediate early IE1 proteins also become associated with extracellular dense bodies despite no reported localization to their intracellular relations ([@bib0365]). Purified extracellular dense bodies are mostly composed of UL83 but have a full complement of viral glycoproteins ([@bib0159]). The function of dense bodies remain unclear, and they may represent the end point of a nonproductive assembly pathway resulting from attempts to envelope capsids lacking genomes or may be used to deliver viral components to neighboring cells.

Interestingly, for human herpesvirus 6 (HHV‐6), the tegument layer appears to be acquired within a dedicated structure that has been dubbed the tegusome ([@bib0303]). This work is based on electron microscopy of cells infected with HHV‐6 and shows tegusomes as intranuclear membrane compartments that abut the nuclear envelope ([Fig. 8D](#fig0008){ref-type="fig"}). Tegusomes may be cytoplasmic invaginations of the nuclear envelope into the nucleus because they appear to contain ribosomes and are sometimes in continuity with the cytoplasm. Nucleocapsids appear to bud into the tegusome, capsids obtain a tegument layer, and then bud into cytoplasmic vacuoles where they acquire envelopes and exit the cell.

VI. Nuclear Inclusions Are Formed by Small DNA Viruses {#sec0048}
======================================================

A. Adenovirus {#sec0049}
-------------

Adenovirus are medium‐sized, nonenveloped dsDNA viruses with genomes ranging from 26 to 45 kbp in length and virions of the order of 70--100 nm in diameter. Like other DNA viruses, they have an ordered cascade of transcripts, early, delayed early, and late types having been described. Adenovirus transcripts are spliced to generate multiple transcripts from a given transcriptional unit. Viral replication occurs in the nucleus, and adenovirus infection was utilized extensively as a model system for exploring different nuclear subcompartments. A productive infection of lytic adenovirus induces profound rearrangement of existing subcompartments and the induction of several new ones within the host nucleus. A study on the localization of the human adenovirus5 IVa2 protein described 10 distinct nuclear and nucleolar subcompartments induced or associated with virus replication ([@bib0197]), and these are listed in [Table I](#tbl0001){ref-type="table"}.

### 1. Structure and location of nuclear inclusions formed during adenovirus replication {#sec0050}

Earlier studies carried out before markers for specific nuclear subcompartments were available have described the structures in terms of shape and location (see [Table I](#tbl0001){ref-type="table"}). During the initial stage of infection, viral RNA ([@bib0283]), single‐stranded DNA (ssDNA), and dsDNA ([@bib0281]) are all synthesized in small fibrillar regions termed early replication sites. By the intermediate stage of replication, the ssDNA is deposited in the center of these structures, while transcription and dsDNA synthesis occur on the outside and begin to form an inclusion. The inclusion has a characteristic doughnut shape, and has been called the fibrogranular network. At late stages of infection, dsDNA, viruses, and trace amounts of ssDNA appear in large viral inclusions ([@bib0026], [@bib0281]). Targeting of the initial replicon is dependent on a dCMP modification of the preterminal protein (pTP), which enables pTP to form a complex with the DNA polymerase and the genome ([@bib0361]). PTP mediates targeting of the heterotrimeric complex to the nuclear matrix ([@bib0122]), possibly through an interaction with CAD (carbamyl phosphate synthetase, aspartate transcarbamylase and dihydroorotase) ([@bib0011]). Transcription and splicing are mediated by host proteins and viral RNA, and non‐SNP RNA splicing factor, hnRNP C proteins, and RNA polymerase II all colocalize with viral RNA in nuclear inclusions. Splicing small nuclear ribonucleoproteins (snRNPs) colocalize with viral RNA but not replication foci ([@bib0274]), and snRNPs then move to interchromatin granules late in infection, which is blocked by mutations in E4 ([@bib0038]).

#### a. Rearrangement of host nuclear compartments during adenovirus replication {#sec0051}

Like herpesvirus described above, adenovirus infection redistributes the components of ND10 bodies. Prior to infection, PML is associated with interchromatin granules but is redistributed to the fibrillogranular matrix within the nucleus along with SP100, another ND10 component ([@bib0054]). Later in infection, PML is redistributed once again from the fibrillogranular matrix to clear amorphous inclusions and protein crystals ([@bib0285]). Another study reported that SP100 and NDP55, but not PML, were relocated from ND10 bodies to viral inclusions ([@bib0097]). While this is confusing, it is clear that adenovirus employs multiple mechanisms to reorganize PML. The initial movement of PML, SP100, and NDP55 to the fibrillogranular matrix occurs prior to viral DNA synthesis and is dependent on the E4‐ORF3 11‐kDa protein ([@bib0054], [@bib0097]). It may also be mediated by E1A proteins that colocalize with PML ([@bib0054]). E1B‐55‐kDa protein also colocalizes with PML early on in infection, then associates with the periphery of replication centers; these interactions are mediated by the ORF6 protein of the E4 transcriptional unit ([@bib0188]). Interestingly, E1B‐55K and E4‐ORF3 target the MRE11‐RAD50‐NBS1 (MRN) complex to aggresomes for degradation ([@bib0014], [@bib0192]). The MRN complex causes concatenation of viral DNA and inhibits packaging. Transport of MRN to the cytoplasm for degradation in aggresomes relieves this inhibition and facilitates production of infectious viruses. The later movement of PML from the fibrillogranular matrix to clear amorphous inclusions also appears important for replication. Movement is mediated by the IX gene product, and adenovirus encoding mutant IX do not create clear amorphous inclusions, have reduced growth, and are sensitive to PML overexpression ([@bib0312]). Interestingly, PKR is also redistributed to clear amorphous inclusions ([@bib0346]) during infection, as are pentons and hexons in the absence of the fiber gene; this suggests these structures may represent sites for sequestering excess viral proteins, and cellular proteins with potentially deleterious effects on the virus ([@bib0286]).

B. Nuclear inclusions formed during polyomavirus and papillomavirus infection {#sec0052}
-----------------------------------------------------------------------------

Polyoma‐ and papillomaviruses are small double‐stranded tumorigenic DNA viruses with genomes of 5 and 8 kbp, respectively. Replication and assembly of these two viruses follow similar strategies, and both involve ND10 bodies. The VP1 capsid protein of human polyomavirus JC is targeted to ND10 domains by VP2, VP3, and agnoprotein where they are assembled into virions ([@bib0335]). A similar process occurs during papillomavirus infection where the minor capsid protein, L2, is responsible for targeting capsomeres of the major capsid protein, L1, to ND10 domains ([@bib0119]). This process involves L2‐induced redistribution of ND10 bodies by targeting SP100 for proteasomal degradation. At this point the cellular Daxx protein is recruited ([@bib0120]). Daax has multiple functions in the nucleus including transcriptional activation and modulating Fas‐mediated apoptosis \[reviewed by [@bib0317]\]. Its role in virus replication is at present unclear.

One characteristic of papillomavirus infections is the appearance of nuclear and cytoplasmic inclusions in cells contained within warts. The size and number of inclusions is dependent on the type of papillomavirus and the site of infection. *Human papillomavirus 1* (HPV‐1), for example, induces many small inclusions while HPV‐4 induces one single inclusion that takes over most of the cytoplasm ([@bib0073]). *In vivo* these structures label strongly with antiserum raised against E4 gene products which are the 17‐kDa E1^∧^E4 and 16‐kDa E4 proteins ([@bib0095], [@bib0304]). Inclusions can be induced in certain cell types *in vitro* by expressing E4 gene products. HPV‐1 E4 staining reveals an initial association with the intermediate filament keratin and subsequent formation of inclusion bodies in the cytoplasm and nucleus ([@bib0300], [@bib0304]). The HPV‐1 cytoplasmic inclusions retain their association with keratin and appear to induce small cages surrounding E4 protein that are interconnected by keratin filaments ([@bib0300]). The E4 gene gives rise to two proteins, the 17‐kDa E1^∧^E4 which can induce cytoplasmic and nuclear inclusions whereas the 16‐kDa E4 can induce inclusions solely in the cytoplasm ([@bib0304]). Interestingly, expression of E1^∧^E4 gene product from HPV‐16 induces the complete collapse of the keratin network, but not that of the microtubule or actin networks ([@bib0096]). It is unclear what the role of the inclusions is in viral replication or the pathology of infection. However, HPV‐1 E4 expression induces the redistribution of ND10 to the periphery of nuclear inclusions in cells in culture, and similar signals are seen *in vivo* ([@bib0300]). The temporal and functional connection between E4 and L1 redistribution of PML is unknown.

VII. Virus Factories and Inclusions Formed by RNA Viruses {#sec0053}
=========================================================

A. Reoviruses {#sec0054}
-------------

Members of the Reoviridae family are dsRNA viruses with segmented genomes and include the clinically important rotavirus and orbiviruses that cause diseases in human and animals. Reoviruses are nonenveloped viruses with genome segments contained inside a virion ∼80 nm in diameter. The genome is encapsidated by two protein shells, an outer capsid and an inner core shell. The core contains the RdRp, capping enzymes, and the dsRNA genome segments \[reviewed in [@bib0400] and [@bib0125])\]. Viruses are taken up by receptor‐mediated endocytosis, the outer capsid is lost and the core is delivered into the cytoplasm. The core does not disassemble on entering cells and imports ribonucleoside triphosphates and *S*‐adenosyl‐[l]{.smallcaps}‐methionine from the cytosol to synthesize and then export viral mRNAs. In this way the core particle functions as a self‐contained transcriptional unit and as such represents the replication complex. Viral mRNA transcribed in the cytoplasm make viral proteins that eventually form large perinuclear inclusions, called virus factories that function as sites of further virus replication and assembly. The Reoviridae family contains 13 genera, and this chapter will concentrate on the two best characterized of these, the orthoreoviruses and rotaviruses.

### 1. Formation of factories during orthoreoviruses replication and assembly {#sec0055}

#### a. The shape of orthoreovirus factories is determined by association with the cytoskeleton {#sec0056}

Orthoreoviruses contain 10 genome segments which are classed by size and then numbered, that is L1 is large segment 1. Large segments encode λ genes, medium (M) segments encode μ genes, and small (S) segments encode σ genes. Virus replication occurs in the cytoplasm in virus factories, and the majority of the virus‐encoded proteins have been shown to localize completely or partially with factories ([Table I](#tbl0001){ref-type="table"}). Early observations revealed that different strains of orthoreoviruses induced factories with different appearances; orthoreovirus type 1 Lang factories were filamentous while the factories of the Dearing isolate of orthoreovirus type 3 were globular ([Fig. 9A and B](#fig0009){ref-type="fig"} ) ([@bib0264]). This difference maps precisely to a serine--proline switch at residue 208 of the μ2 core protein ([@bib0264]). Control of the localization of orthoreovirus factories reflects the degree of association μ2 has with the microtubule network. Filamentous virus μ2 stabilizes microtubules to a greater relative degree than globular virus μ2, and depolymerizing microtubules with nocodazole convert filamentous factories to globular ones.Figure 9(A and B) Confocal images of orthoreovirus type 3 Dearing (A)‐ and type 1 Lang (B)‐infected cells labeled with showing difference between globular and filamentous types of viral factories. (C) Confocal image of an infected cell immunolabeled with (red) and α‐tubulin (green) showing relationship between filamentous factories and microtubules. Reprinted from [@bib0264] with permission from American Society for Microbiology. (D) Electron micrograph showing rotavirus viroplasm (V) next to TLP within membranes derived from the ER (arrow). Reprinted from [@bib0271] with permission from Elsevier. (E) Doughnut‐shaped rotavirus factory labeled with anti‐NSP2 antibody showing electron‐lucent center with electron‐dense core (arrow) surrounded by viroplasm (V). Reprinted from [@bib0007] with permission from Society for General Microbiology.

#### b. Virus nonstructural proteins determine orthoreovirus factory organization {#sec0057}

Many of the events of orthoreovirus factory formation have been successfully reconstituted *in vitro*. A screen of orthoreovirus proteins revealed that μNS, σNS, and σ3 were the first viral proteins to localize with viral mRNA prior to the synthesis of progeny dsRNA ([@bib0012]). Subsequently, it was discovered that expression of the μNS protein of isolate Dearing in the absence of other viral proteins induced a phase‐dense structure that was indistinguishable in appearance from that observed during wild‐type infection ([@bib0039]). The shape of the artificial μNS inclusion could be altered from globular to filamentous by coexpressing a μ2 protein from a filamentous virus ([@bib0039]). Similar experiments showed that coexpression of λ1, λ2, and σ2 core surface proteins with μNS caused them to localize to the μNS inclusion ([@bib0040]). Furthermore, the shape of the μNS structure that the core proteins colocalized to could be altered to filamentous by coexpressing μ2 from a filamentous virus ([@bib0040]). μNS can also recruit σNS, but not σ3, to artificial inclusions ([@bib0021]), so other factors or conditions are necessary for complete assembly of an orthoreovirus factory. The precise domains involved in initiating factory formation are beginning to be elucidated. The minimal region of μNS necessary for inclusion like body formation *in vitro* is the region composed of 250 C‐terminal amino acids of the 721 residue proteins ([@bib0041]). Residues 1--11 of σNS are important for the interaction between σNS and RNA ([@bib0129]), and treatment with RNase dissociates a proportion of μNS from σNS in coimmunoprecipiation experiments ([@bib0220]). Interaction between μNS and μ2 is dependent on residues 1--40 or 41 of μNS ([@bib0039]) and residues 1--13 are necessary for interaction between μNS and σNS ([@bib0220]). It is likely that factory formation occurs through an interaction between μNS and a σNS‐RNA complex; this can then recruit μ2 that will determine the globular or filamentous localization of the factory and hence the localization of the other viral proteins.

Orthoreovirus factories are clearly intimately associated with the microtubule network ([Fig. 9C](#fig0009){ref-type="fig"}) and have also been suggested to interact with intermediate filaments. Orthoreovirus type 3 infection induces a redistribution of vimentin and viral inclusions reported to contain filamentous structures ([@bib0331]). It will be interesting to see if the *in vitro* factories induced by μNS can also alter the distribution of the intermediate filament network. Orthoreovirus factories are also ubiquitinated, and interestingly the nature of the factory determined the degree of ubiquitination; globular factories are prone to contain more ubiquitinated protein than filamentous ones ([@bib0221]). Ubiquitination of orthoreovirus factories has been mapped to the μ2 protein but is independent of the filamentous/globular factory determinate of μ2, that is converting a filamentous factory to a globular factory does not lead to an increase in ubiquitinated μ2.

### 2. Formation of factories during rotavirus replication and assembly {#sec0058}

#### a. Virus nonstructural proteins organize factory formation and virus assembly {#sec0059}

Rotaviruses contain 11 genome segments of dsRNA and like the orthoreoviruses replicate in cytoplasmic factories. Rotavirus virions are composed of three protein layers. These are the core which contains the genome and polymerase, an inner capsid layer, and an outer capsid layer.The core and inner capsid layer comprise the double‐layered particle (DLP), while the addition of the third capsid layer forms the mature triple‐layered particle (TLP). The acquisition of the third capsid layer occurs after the virus buds into the ER, and in doing so obtains a transient envelope. Rotavirus factories are composed of electron‐dense viroplasm often in proximity to membranes derived from the ER ([Fig. 9D](#fig0009){ref-type="fig"}) ([@bib0007]). Viroplasm contains high levels of NSP2 ([Fig. 9E](#fig0009){ref-type="fig"}) and NSP5 which are thought to coordinate assembly of the factory and recruitment of structural proteins such as the inner core protein VP2 and viral polymerase VP1. The factory also contains double‐layered rotaviruses, whereas the ER membranes associated with the factory contain enveloped intermediates and TLP (arrowed in [Fig. 9D](#fig0009){ref-type="fig"}). Virus factories grow in size and decrease in number during the course of infection as neighboring factories merge ([@bib0105]). Rotavirus factories appear to have an internal structure, as their centers occasionally appear more electron lucent than the periphery, giving a doughnut‐like appearance ([Fig. 9E](#fig0009){ref-type="fig"}). Electron microscopy shows DLP at the periphery of the factory and this is ([@bib0007]) consistent with fluorescent microscopy showing that the nonstructural protein NSP2 localizes to the center of the virus factory, whereas NSP5 and inner capsid protein VP6 localize to the periphery ([@bib0105], [@bib0130]). These different localizations could have functional relevance because VP6 binds the ER‐targeted NSP4 membrane protein and is implicated in the budding of DLPs into ER membranes associated with factories ([@bib0338]). Therefore, a localization to the exterior of the factory may represent an organized progression of virus maturation from the interior of the viroplasm to the exterior. However, things are probably not that straightforward because VP6 is also part of the viral RNA complex along with NSP2 ([@bib0013]) which, as noted above, is localized to the center of the viroplasm.

Virus factory‐like structures can be introduced *in vitro* by coexpressing NSP2 and NSP5 ([@bib0117]), and this is regulated by domains in the N‐ and C‐termini ([@bib0117]) as well as the central portion of NSP5 ([@bib0104]). The process is also dependent on phosphorylation of NSP5, possibly by cellular casein kinase II ([@bib0104]). Structures similar to factories can also be induced by expressing the inner capsid protein VP6 *in vitro* ([@bib0255]). These structures look similar to factories in the electron microscope but lack electron‐lucent areas and DLPs. Interestingly, expression of VP6 of group A simian rotavirus SA‐11 induced globular structures, whereas expression of VP6 from group C porcine rotavirus Cowden/AmC‐1 induced filamentous structures ([@bib0255]) analogous to the difference between type 1 and type 3 orthoretroviruses. It is not clear if the difference in factory shape is solely determined by VP6 and if this involves differences in association of the factory components with microtubules.

#### b. Virus factories organize viral RNA replication and translation {#sec0060}

The factory does provide the virus with a mechanism to organize viral RNAs. Positive‐stranded viral RNA is utilized as the template for synthesizing progeny dsRNA genomes and as mRNA for translating viral proteins. Interestingly, siRNA‐targeted degradation of NSP1 RNA blocks translation of the protein but does not block genome synthesis ([@bib0337]). Furthermore, RNA synthesis occurs in factories, but viral RNA transcribed *in vitro* and introduced to infected cells after infection does not localize to factories. The implication of these experiments are that the factory enables rotavirus to sort viral RNA into separate pools, one within the factory to act as a template for the RNA polymerase and genome replication, and the other outside the factory where it translated on ribosomes to make viral proteins. It likely that this organization allows the virus factory to protect dsRNA genomes from antiviral responses.

B. Inclusions formed during arenavirus infection {#sec0061}
------------------------------------------------

Arenaviruses are negative‐stranded RNA viruses that have two single‐stranded genome segments which are packaged into 60‐ to 200‐nm‐diameter enveloped virions. Lassa, Junín, and Manchupo viruses are responsible for emerging hemorraghic fevers in humans. Arenaviruses induce moderately electron‐dense inclusions in the cytoplasm that are composed of 20‐ to 25‐nm‐diameter granules identical to those seen within virus particles in the electron microscope ([@bib0238]). The granules represent host ribosomes and between 2 and 10 are packaged into virions ([@bib0266]). The inclusions increase in size and density during infection until cytopathic effects are observed in cells ([@bib0046], [@bib0047]) and stain positive for viral antigens ([@bib0399]); however, it is unclear if they represent true virus factories. Arenavirus replication is believed to occur in the cytoplasm but also requires a nuclear step as limited growth is observed in enucleated cells ([@bib0017]). The viral Z protein may play a role in this as it is sufficient *in vitro* to shuttle PML from the nucleus to cytoplasmic inclusion bodies as occurs *in vivo* ([@bib0033]). N protein also localizes to discrete nuclear foci, as well as in the cytoplasm ([@bib0399]), but the relationship to ND10 bodies and Z protein is unknown.

C. Inclusions formed during rabies virus infection {#sec0062}
--------------------------------------------------

*Rabies virus* is a neurotropic lyssavirus of the rhabdovirus family. Rhabdovirus virions are bullet‐shaped 180 × 75 nm^2^ particles containing a single negative strand of RNA. Rabies induces two types of inclusion body *in vitro*, neither of which have been proven as replication sites. Negri bodies are induced by street rabies viruses in infected neurons of the brain ([@bib0244]) and are a good indicator for the presence of an infection site in tissue ([@bib0163]). Different neuronal cell types appear to be more prone to Negri bodies ([@bib0163]). Negri bodies contain innerbodies ([@bib0245]) and electron microscopic studies suggest the subcompartments may be cytoplasmic material engulfed by the coalescence of several smaller Negri bodies ([@bib0209]). The role of Negri bodies in infection is poorly understood. Initial EM observations showed virions localized to some bodies in some cells ([@bib0210]), and cytological staining show they contain genetic material, indicating they may be replication complexes. However, ^3^H‐thymidine or ^3^H‐uridine fail to label the structures, arguing against this conclusion ([@bib0209]). Fixed (brain‐adapted laboratory strains) rabies can infect nonneuronal cell lines and in these cell types induce fuchsin‐stained cytoplasmic structures (FCPS) as well as Negri‐like bodies ([@bib0253]). FCPS increase in size during infection that correlates with cytopathic effects and are composed of rabies glycoprotein and matrix protein, whereas Negri bodies contain nucleocapsid ([@bib0253]).

VIII. Conclusions {#sec0063}
=================

This chapter has described the changes to cell architecture that are induced during virus replication. We have focused on viruses that induce new cellular structures, such as inclusion bodies, virus factories, or replication complexes, to concentrate virus and host factors necessary for replication and assembly. Much progress has been made in identifying which cellular components are used to generate these structures, and in some cases specific virus proteins have been identified that are able to induce them. Virus inclusions often result in rearrangement of cellular membrane compartments and/or cytoskeleton. The functions of these organelles are carefully regulated in cells, and it is a challenge for the future to determine how viruses disrupt them for use as sites of replication and assembly. Changes in cellular architecture may represent bystander responses to the stress associated with virus infection, and some viruses may replicate perfectly well without them. Alternatively, viruses may have evolved to target key stages in the regulatory pathways that control organelle structure and function to generate sites that are essential for replication and assembly. Given the coevolution of viruses with the cells that carry them, changes in cell structure induced during infection are likely to involve a combination of the two. It is also important to appreciate that many of the structures that have been studied to date have been generated by infecting tissue culture cells with attenuated viruses, often with disregard to the host range and tropism. It is possible that in the natural setting, changes in cell structure induced by viruses will be more subtle, particulary during persistent infections that occur without inflammation or cell lysis.

Human herpesvirus 1 is herpes simplex virus 1 and human herpesvirus 2 is herpes simplex virus 2.

Suid herpesvirus 1 is pseudorabiesvirus or Aujesky\'s disease virus.

Human herpesvirus 5 is human cytomegalovirus.

[^1]: *African swine fever virus* gene nomenclature is based on that for the Badajoz 1971 vero adapted strain with that of the Malawi Lil 20/1 strain in parentheses.

[^2]: *Vaccinia virus* gene nomenclature is based on that for the Copenhagen strain with that of the western reserve strain in parentheses.

[^3]: One report places in ERGIC‐53 within the virosome ([@bib0298]), one report places it outside ([@bib0156]).

[^4]: Open reading frames from human herpesvirus 1 (herpes simplex virus 1) unless specified otherwise.

[^5]: Open reading frames from human herpesvirus 5 (human cytomegalovirus) unless specified.

[^6]: Proteins specified by frog virus 3 unless indicated otherwise.
